Borhane Annabi

Borhane Annabi

Professeur
Photo de Borhane Annabi
Liens d'intérêt
Informations générales

Cheminement académique

1999-2001 Stage Post-Doctoral en Cancérologie
Sainte-Justine Pediatric Hospital Research Centre (Montreal, Canada)
"Pathophysiology and molecular regulation of MT1-MMP in tumor angiogenesis"


1997-1998 Stage Post-Doctoral en Génétique
National Institute of Child Health and Human Development (Bethesda, USA)
"Molecular genetics of the heritable Glycogen Storage Disease type 1"


1997 Doctorat en Biochimie
Metabolic Endocrinology Laboratory, Université de Montréal
"Transport and hydrolytic functions of the liver microsomal glucose-6-phosphatase system"


1994 Maitrise en Biochimie
Metabolic Endocrinology Laboratory, Université de Montréal
"Defects in the hepatic glycogen metabolism : Etiological study in the genetically obese (fa/fa) Zucker rat"


1990 Baccalauréat en Biochimie
Université de Montréal

Unités de recherche

Projets de recherche en cours

  • Anti-cancer diet-derived compounds identification : Assessment of chemopreventive and therapeutic properties (Fondation - UQAM)

  • Probing into receptor­-mediated trafficking and internalization functions of biologically active peptides (CRSNG-SD)

  • Preclinical Development of A Novel Targeted And Personalized Treatment Against Sortilin-Positive Breast Cancer (CQDM - SynergiQc)

Partenaires (organismes, entreprises)

  • CRSNG-SD / CRSNG-RDC / FQRNT / FCI / CQDM-SynergiQc / Theratechnologies Inc.

Affiliations externes principales

Enseignement
Distinctions

Directions de thèses et mémoires

Thèses de doctorat
Mémoires
Autres directions et supervisions
  • Annabi, Bayader. (2016). Impact des cavines sur le phénotype invasif et inflammatoire des cellules souches mésenchymateuses. (Mémoire de maîtrise). Université de Montréal.
  • Vézina, Amélie. (2012). Impact du statut de différenciation des cellules promyélocytaires HL-60 sur l'efficacité anticancéreuse et anti-inflammatoire de l'EGCG. (Mémoire de maîtrise). Université de Montréal.

Publications

Articles scientifiques
  • Uthamacumaran, A., Gonzalez Suarez, N., Baniré Diallo, A. et Annabi, B. (2021). Computational Methods for Structure-to-Function Analysis of Diet-Derived Catechins-Mediated Targeting of In Vitro Vasculogenic Mimicry. Cancer Informatics, 20, 1–8. http://dx.doi.org/10.1177/11769351211009229.
  • Mélin, L., Abdullayev, S., Fnaiche, A., Gonzalez Suarez, N., Vu, V., Li, F., Zeng, H., Li, F., Senisterra, G., Allali-Hassani, A., Dong, A., Woo, S., Halabelian, L., Vedadi, M., Barsyte-Lovejoy, D., Annabi, B., Laplante, S., Santhakumar, V. et Gagnon, A. (2021). Development of LM98, a small-molecule TEAD inhibitor derived from flufenamic acid. ChemMedChem, 16(19), 2982–3002. http://dx.doi.org/10.1002/cmdc.202100432.
  • Sicard, A.A., Dao, T., Gonzalez Suarez, N. et Annabi, B. (2021). Diet-derived gallated catechins prevent TGF-β-mediated epithelial-mesenchymal transition, cell migration and vasculogenic mimicry in chemosensitive ES-2 ovarian cancer cells. Nutrition and Cancer, 73(1), 169–180. http://dx.doi.org/10.1080/01635581.2020.1733624.
  • González Suárez, N., Rodriguez Torres, S., Ouanouki, A., El Cheikh-Hussein, L. et Annabi, B. (2021). EGCG inhibits adipose-derived mesenchymal stem cells differentiation into adipocytes and prevents a STAT3-mediated paracrine oncogenic control of triple-negative breast cancer cell invasive phenotype. Molecules, 26(6), article 1506. http://dx.doi.org/10.3390/molecules26061506.
  • Abusarah, J., Khodayarian, F., El-Hachem, N., Cui, Y., Olivier, M., Balood, M., Roversi, K., Talbot, S., Bikorimana, J.P., Chen, J., Jolicoeur, M., Ramet, L., Kamyabiazar, S., Annabi, B., Robert, C.F., Pelletier, J., El-Khadiry, A., Shammaa, R. et Rafei, M. (2021). Engineering a potent cancer vaccine using immunoproteasome-expressing mesenchymal stromal cells. Cell Reports Medicine.
    Notes: (sous presse)
  • Sicard, A.A., Gonzalez Suarez, N., Cappadocia, L. et Annabi, B. (2021). Functional targeting of the TGF-βR1 kinase domain and downstream signaling: A role for the galloyl moiety of green tea-derived catechins in ES-2 ovarian clear cell carcinoma. Journal of Nutritional Biochemistry, 87, article 108518. http://dx.doi.org/10.1016/j.jnutbio.2020.108518.
  • Hajjar, R., Oliero, M., Cuisiniere, T., Fragoso, G., Calvé, A., Djediai, S., Annabi, B., Richard, C.S. et Santos, M.M. (2021). Improvement of colonic healing and surgical recovery with perioperative supplementation of inulin and galacto-oligosaccharides. Clinical Nutrition, 40(6), 3842–3851. http://dx.doi.org/10.1016/j.clnu.2021.04.032.
  • Charfi, C., Demeule, M., Currie, J.C., Larocque, A., Zgheib, A., Danalache, B.A., Ouanouki, A., Béliveau, R., Marsolais, C. et Annabi, B. (2021). New peptide-drug conjugates for precise targeting of SORT1-mediated vasculogenic mimicry in the tumor microenvironment of TNBC-derived MDA-MB-231 breast and ovarian ES-2 clear cell carcinoma cells. Frontiers in Oncology, 11, article 760787. http://dx.doi.org/10.3389/fonc.2021.760787.
  • AbuSarah, J., Cui, Y., EL-Hachem, N., El-Kadiry, A.E., Martel, I.H., Wurtele, H., Beaudry, A., Raynal, N., Robert, F., Pelletier, J., Jankovic, M., Mercier, F., Kamyabiazar, S., Annabi, B. et Rafei, M. (2021). TACIMA-218: A Novel Pro-Oxidant Agent Exhibiting Selective Antitumoral Activity. Molecular Cancer Therapeutics, 20(1), 37–49. http://dx.doi.org/10.1158/1535-7163.MCT-20-0333.
  • Demeule, M., Charfi, C., Currie, J.C., Larocque, A., Zgheib, A., Kozelko, S., Béliveau, R., Marsolais, C. et Annabi, B. (2021). TH1902, a new docetaxel-peptide conjugate for the treatment of sortilin-positive triple-negative breast cancer. Cancer Science, 112(10), 4317–4334. http://dx.doi.org/10.1111/cas.15086.
  • Martin, A.C., Tomasin, R., Luna-Dulcey, L., Graminha, A.E., Naves, M.A., Gomes Teles, R.H., da Silva, V.D., da Silva, J.A., Vieira, P.C., Annabi, B. et Cominetti, M.R. (2020). Gingerol improves doxorubicin anticancer activity and decreases its side effects in triple negative breast cancer models. Cellular Oncology, 43(5), 915–929. http://dx.doi.org/10.1007/s13402-020-00539-z.
  • Dao, T., Salahuddin, S., Charfi, C., Sicard, A.A., Jenabian, M.A. et Annabi, B. (2020). Pharmacological targeting of neurotensin response by diet-derived EGCG in macrophage-differentiated HL-60 promyelocytic leukemia cells. PharmaNutrition, 12, article 100191. http://dx.doi.org/10.1016/j.phanu.2020.100191.
  • Desjarlais, M. et Annabi, B. (2019). Dual functions of ARP101 in targeting membrane type-1 matrix metalloproteinase: Impact on U87 glioblastoma cell invasion and autophagy signaling. Chemical Biology & Drug Design, 93(3), 272–282. http://dx.doi.org/10.1111/cbdd.13410.
  • Francisco Fernandez, M., Charfi, C., Piloto-Ferrer, J., González, M.L., Lamy, S. et Annabi, B. (2019). Targeting Ovarian Cancer Cell Cytotoxic Drug Resistance Phenotype with Xanthium strumarium L. Extract. Evidence-Based Complementary and Alternative Medicine, 2019, Article ID 6073019. http://dx.doi.org/10.1155/2019/6073019.
  • Lamy, S., Muhire, E. et Annabi, B. (2018). Antiproliferative efficacy of elderberries and elderflowers (Sambucus canadensis) on glioma and brain endothelial cells under normoxic and hypoxic conditions. Journal of Functional Foods, 40, 164–179. http://dx.doi.org/10.1016/j.jff.2017.10.048.
  • Djerir, D., Iddir, M., Bourgault, S., Lamy, S. et Annabi, B. (2018). Biophysical evidence for differential gallated green tea catechins binding to membrane type-1 matrix metalloproteinase and its interactors. Biophysical Chemistry, 234, 34–41. http://dx.doi.org/10.1016/j.bpc.2018.01.002.
  • Vézina, A., Charfi, C., Zgheib, A. et Annabi, B. (2018). Cerebrovascular angiogenic reprogramming upon LRP1 repression: Impact on sphingosine-1-phosphate-mediated signaling in brain endothelial cell chemotactism. Molecular Neurobiology, 55(4), 3551–3563. http://dx.doi.org/10.1007/s12035-017-0614-3.
  • Ouanouki, A., Lamy, S. et Annabi, B. (2018). Periostin, a signal transduction intermediate in TGF-β-induced EMT in U-87MG human glioblastoma cells, and its inhibition by anthocyanidins. Oncotarget, 9(31), 22023–22037. http://dx.doi.org/10.18632/oncotarget.25153.
  • Sheehy, S. et Annabi, B. (2017). A transcriptional regulatory role for the membrane type-1 matrix metalloproteinase in carcinogen-induced inflammasome gene expression. Gene Regulation and Systems Biology, 11, 1–13. http://dx.doi.org/10.1177/1177625017713996.
  • Ouanouki, A., Lamy, S. et Annabi, B. (2017). Anthocyanidins inhibit epithelial-mesenchymal transition through a TGF-β/Smad2 signaling pathway in glioblastoma cells. Molecular Carcinogenesis, 56(3), 1088–1099. http://dx.doi.org/10.1002/mc.22575.
  • Annabi B., Zgheib, A. et Annabi, B. (2017). Cavin-2 functions as a suppressive regulator in TNF-induced mesenchymal stromal cell inflammation and angiogenic phenotypes. International Journal of Stem Cells, 10(1), 103–113. http://dx.doi.org/10.15283/ijsc16032.
  • Zehtabi, F., Ispas-Szabo, P., Djerir, D., Sivakumaran, L., Annabi, B., Soulez, G., Mateescu, M. A. et Lerouge, S. (2017). Chitosan-Doxycycline hydrogel: an MMP inhibitor/sclerosing embolizing agent as a new approach to endoleak prevention and treatment after endovascular aneurysm repair. Acta Biomaterialia, 64, 94–105. http://dx.doi.org/10.1016/j.actbio.2017.09.021.
  • Pratt, J., Iddir, M., Bourgault, S. et Annabi, B. (2016). Evidence of MTCBP-1 interaction with the cytoplasmic domain of MT1-MMP: Implications in the autophagy index of high grade glioblastoma. Molecular Carcinogenesis, 55(2), 148–160. http://dx.doi.org/10.1002/mc.22264.
  • Burke-Nanni, S., Pratt, J., Beauchemin, D., Haidara, K. et Annabi, B. (2016). Impact of concanavalin-a-mediated cytoskeleton disruption on low-density lipoprotein receptor-related protein-1 internalization and cell surface expression in glioblastomas. Biomarkers in Cancer, 8, 77–87. http://dx.doi.org/10.4137/BIC.S38894.
  • Lamy, S., Ben Saad, A., Zgheib, A. et Annabi, B. (2016). Olive oil compounds inhibit the paracrine regulation of TNF-alpha-induced endothelial cell migration through reduced glioblastoma cell cyclooxygenase-2 expression. Journal of Nutritional Biochemistry, 27, 136–145. http://dx.doi.org/10.1016/j.jnutbio.2015.08.026.
  • Regina, A., Demeule, M., Tripathy, S., Lord-Dufour, S., Currie, J.-C., Castaigne, J.-P., Iddir, M., Annabi, B. et Lachowicz, J. E. (2015). ANG4043, a novel brain-penetrant peptide-mAb conjugate, is efficacious against HER2-positive intracranial tumors in mice. Molecular Cancer Therapeutics, 14(1), 129–140. http://dx.doi.org/10.1158/1535-7163.MCT-14-0399.
  • Lamy, S., Moldovan, P.L., Ben Saad, A. et Annabi, B. (2015). Biphasic effects of luteolin on interleukin-1β-induced cyclooxygenase-2 expression in glioblastoma cells. Biochimica et Biophysica Acta (BBA) – Molecular Cell Research, 1853(1), 126–135. http://dx.doi.org/10.1016/j.bbamcr.2014.10.010.
  • Wagner, M., Ohlund, L., Shiao, T.C., Vézina, A., Annabi, B., Roy, R. et Sleno, L. (2015). Isotope-labeled differential profiling of metabolites using N-benzoyloxysuccinimide derivatization coupled to liquid chromatography/high-resolution tandem mass spectrometry. Rapid Communications in Mass Spectrometry, 29(18), 1632–1640. http://dx.doi.org/10.1002/rcm.7264.
  • Toufaily, C., Charfi, C., Annabi, B. et Annabi, B. (2014). A role for the Cavin-3/matrix metalloproteinase-9 signalling axis in the regulation of PMA-activated human HT1080 fibrosarcoma cell neoplastic phenotype. Cancer Growth and Metastasis, 7, 43–51. http://dx.doi.org/10.4137/CGM.S18581.
  • Gupta, R., Toufaily, C. et Annabi, B. (2014). Caveolin and cavin family members: dual roles in cancer. Biochimie, 107(Part B), 188–202. http://dx.doi.org/10.1016/j.biochi.2014.09.010.
  • Pratt, J. et Annabi, B. (2014). Induction of autophagy biomarker BNIP3 requires a JAK2/STAT3 and MT1-MMP signaling interplay in Concanavalin-A-activated U87 glioblastoma cells. Cellular Signalling, 26(5), 917–924. http://dx.doi.org/10.1016/j.cellsig.2014.01.012.
  • Vézina, A., Vaillancourt-Jean, E., Albarao, S. et Annabi, B. (2014). Mesenchymal stromal cell ciliogenesis is abrogated in response to tumor necrosis factor-alpha and requires NF-kB signaling. Cancer Letters, 345(1), 100–105. http://dx.doi.org/10.1016/j.canlet.2013.11.021.
  • Desjarlais, M., Pratt, J., Lounis, A., Mounier, C., Haidara, K. et Annabi, B. (2014). Tetracycline derivative minocycline inhibits autophagy and inflammation in concanavalin-A-activated human hepatoma cells. Gene Regulation and Systems Biology, 8, 63–73. http://dx.doi.org/10.4137/GRSB.S13946.
  • Chokor, R., Lamy, S. et Annabi, B. (2014). Transcriptional targeting of sphingosine-1- phosphate receptor S1P2 by epigallocatechin- 3-gallate prevents sphingosine-1-phosphate- mediated signaling in macrophage-differentiated HL -60 promyelomonocytic leukemia cells. OncoTargets and Therapy, 7, 667–677. http://dx.doi.org/10.2147/OTT.S62717.
  • Zgheib, A., Lamy, S. et Annabi, B. (2013). Epigallocatechin gallate targeting of membrane type 1 matrix metalloproteinase-mediated src and janus kinase/signal transducers and activators of transcription 3 signaling inhibits transcription of colony-stimulating factors 2 and 3 in mesenchymal stromal cells. Journal of Biological Chemistry, 288(19), 13378–13386. http://dx.doi.org/10.1074/jbc.M113.456533.
  • Annabi, B., Vaillancourt-Jean, E. et Béliveau, R. (2013). MT1-MMP expression level status dictates the in vitro action of lupeol on inflammatory biomarkers MMP-9 and COX-2 in medulloblastoma cells. Inflammopharmacology, 21(1), 91–99. http://dx.doi.org/10.1007/s10787-012-0142-8.
  • Zgheib, A., Pelletier-Bonnier, E., Levros, L.C. et Annabi, B. (2013). Selective JAK/STAT3 signalling regulates transcription of colony stimulating factor-2 and-3 in Concanavalin-A-activated mesenchymal stromal cells. Cytokine, 63(2), 187–193. http://dx.doi.org/10.1016/j.cyto.2013.04.027.
  • Sartelet, H., Imbriglio, T., Nyalendo, C., Haddad, E., Annabi, B., Duval, M., Fetni, R., Victor, K., Alexendrov, L., Sinnett, D., Fabre, M. et Vassal, G. (2012). CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway. Histopathology, 60(7), 1144–1155. http://dx.doi.org/10.1111/j.1365-2559.2012.04191.x.
  • Akla, N., Pratt, J. et Annabi, B. (2012). Concanavalin-A triggers inflammatory response through JAK/STAT3 signalling and modulates MT1-MMP regulation of COX-2 in mesenchymal stromal cells. Experimental Cell Research, 318(19), 2498–2506. http://dx.doi.org/10.1016/j.yexcr.2012.08.003.
  • Pratt, J., Roy, R. et Annabi, B. (2012). Concanavalin-A-induced autophagy biomarkers requires membrane type-1 matrix metalloproteinase intracellular signaling in glioblastoma cells. Glycobiology, 22(9), 1245–1255. http://dx.doi.org/10.1093/glycob/cws093.
  • Vezina, A., Chokor, R. et Annabi, B. (2012). EGCG targeting efficacy of NF-kappa B downstream gene products is dictated by the monocytic/macrophagic differentiation status of promyelocytic leukemia cells. Cancer Immunology Immunotherapy, 61(12), 2321–2331. http://dx.doi.org/10.1007/s00262-012-1301-x.
  • Annabi, B., Lord-Dufour, S., Vézina, A. et Béliveau, R. (2012). Resveratrol targeting of carcinogen-induced brain endothelial cell inflammation biomarkers MMP-9 and COX-2 is sirt1-independent. Drug Target Insights, 6, 1–11. http://dx.doi.org/10.4137/DTI.S9442.
  • Proulx-Bonneau, S., Guezguez, A. et Annabi, B. (2011). A concerted HIF-1α/MT1-MMP signalling axis regulates the expression of the 3BP2 adaptor protein in hypoxic mesenchymal stromal cells. PLoS ONE, 6(6), e21511. http://dx.doi.org/10.1371/journal.pone.0021511.
  • Annabi, B., Proulx-Bonneau, S. et Pratt, J. (2011). A role for MT1-MMP as a cell death sensor/effector through the regulation of endoplasmic reticulum stress in glioblastoma cells. Journal of Neuro-Oncology, 104(1), 33–43. http://dx.doi.org/10.1007/s11060-010-0468-2.
  • Kuss, S., Cornut, R., Beaulieu, I., Mezour, M.A., Annabi, B. et Mauzeroll, J. (2011). Assessing multidrug resistance protein 1-mediated function in cancer cell multidrug resistance by scanning electrochemical microscopy and flow cytometry. Bioelectrochemistry, 82(1), 29–37. http://dx.doi.org/10.1016/j.bioelechem.2011.04.008.
  • Sina, A., Lord-Dufour, S., Roy, R. et Annabi, B. (2011). Ciblage pharmacologique de la MT1-MMP dans les cellules tumorales cérébrales par l'actinonine, un inhibiteur de l'aminopeptidase N/CD13. Bio Tribune Magazine, 38(1), 39–45. http://dx.doi.org/10.1007/s11834-011-0042-z.
  • Tahanian, T., Sanchez, L.A., Shiao, T.C., Roy, R. et Annabi, B. (2011). Flavonoids targeting of IkB phosphorylation abrogates carcinogen-induced MMP-9 and COX-2 expression in human brain endothelial cells. Drug Design, Development and Therapy, 5, 299–309. http://dx.doi.org/10.2147/DDDT.S19931.
  • Annabi, B., Tahanian, E., et Peiro, S. (2011). Low intracellular ATP levels exacerbate carcinogen-induced inflammatory stress response and inhibit in vitro tubulogenesis in human brain endothelial cells. Journal of Inflammation Research, 4, 1–10. http://dx.doi.org/10.2147/JIR.S15880.
  • Proulx-Bonneau, S. et Annabi, B. (2011). The primary cilium as a biomarker in the hypoxic adaptation of bone marrow-derived mesenchymal stromal cells: A role for the secreted frizzled-related proteins. Biomarker Insights, 6, 107–118. http://dx.doi.org/10.4137/BMI.S8247.
  • Tahanian, E., Lord‐dufour, S., Das, A., Khosla, C., Roy, R. et Annabi, B. (2010). Inhibition of Tubulogenesis and of Carcinogen‐mediated Signaling in Brain Endothelial Cells Highlight the Antiangiogenic Properties of a Mumbaistatin Analog. Chemical Biology & Drug Design, 75(5), 481–488. http://dx.doi.org/10.1111/j.1747-0285.2010.00961.x.
  • Annabi, B., Doumit, J., Plouffe, K., Laflamme, C., Lord-Dufour, S. et Béliveau, R. (2010). Members of the low-density lipoprotein receptor-related proteins provide a differential molecular signature between parental and CD133(+) DAOY medulloblastoma cells. Molecular Carcinogenesis, 49(7), 710–717. http://dx.doi.org/10.1002/mc.20645.
  • Annabi, B., Vaillancourt-Jean, E., Weil, A.G. et Béliveau, R. (2010). Pharmacological targeting of β-adrenergic receptor functions abrogates NF-κB signaling and MMP-9 secretion in medulloblastoma cells. OncoTargets and Therapy, 3, 219–226. http://dx.doi.org/10.2147/OTT.S14503.
  • Sina, A., Proulx-Bonneau, S., Roy, A., Poliquin, L., Cao, J. et Annabi, B. (2010). The lectin concanavalin-A signals MT1-MMP catalytic independent induction of COX-2 through an IKKγ/NF-κB-dependent pathway. Journal of Cell Communication and Signaling, 4(1), 31–38. http://dx.doi.org/10.1007/s12079-009-0084-0.
  • Annabi, B., Laflamme, C., Sina, A., Lachambre, M.P. et Beliveau, R. (2009). A MT1-MMP/NF-kappa B signaling axis as a checkpoint controller of COX-2 expression in CD133(+) U87 glioblastoma cells. Journal of Neuroinflammation, 6(1), 8–18. http://dx.doi.org/10.1186/1742-2094-6-8.
  • Annabi, B., Sina, S. et Lord-Dufour, S. (2009). Cell-based evidence for aminopeptidase N/CD13 inhibitor actinonin targeting of MT1-MMP-mediated proMMP-2 activation. Cancer Letters, 279(2), 171–176. http://dx.doi.org/10.1016/j.canlet.2009.01.032.
  • Lord-Dufour, S., Copland, I.B., Levros, L.C., Post, M., Das, A., Khosla, C., Galipeau, J., Rassart, E. et Annabi, B. (2009). Evidence for transcriptional regulation of the glucose-6-phosphate transporter by HIF-1alpha: targeting G6PT with mumbaistatin analogs in hypoxic mesenchymal stromal cells. Stem Cells, 27(3), 489–497. http://dx.doi.org/10.1634/stemcells.2008-0855.
  • Copland, I.B., Lord-Dufour, S., Cuerquis, J., Coutu, D.L., Annabi, B., Wang, E. et Galipeau, J. (2009). Improved Autograft Survival of Mesenchymal Stromal Cells by Plasminogen Activator Inhibitor 1 Inhibition. Stem Cells, 27(2), 467–477. http://dx.doi.org/10.1634/stemcells.2008-0520.
  • Annabi, B., Lachambre, M.-P., Plouffe, K., Sartelet, H. et Béliveau, R. (2009). Modulation of invasive properties of CD133(+) glioblastoma stem cells: A role for MT1-MMP in bioactive lysophospholipid signaling. Molecular Carcinogenesis, 48(10), 910–919. http://dx.doi.org/10.1002/mc.20541.
  • Annabi, B., Lachambre, M.-P., Plouffe, K., Moumdjian, R. et Béliveau, R. (2009). Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion. Pharmacological Research, 60(5), 438–445. http://dx.doi.org/10.1016/j.phrs.2009.05.005.
  • Annabi, B., Copland, I. B., Jolicoeur, M. E., Gillis, M. A., Cerquis, j., Eliopoulos, N., Calderone, A., Tanguay, J.F., Ducharme, A. et Galipeau, J. (2008). Coupling erythropoietin secretion to mesenchymal stromal cells enhances their regenerative properties. Cardiovascular Research, 79(3), 405–415. http://dx.doi.org/10.1093/cvr/cvn090.
  • Rafei, M., Hsieh, J., Fortier, S., Li, M.Y., Yuan, S., Birman, E., Forner, K., Boivin, M.N., Doody, K., Tremblay, M., Annabi, B. et Galipeau, J. (2008). Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction. Blood, 112(13), 4991–4998. http://dx.doi.org/10.1182/blood-2008-07-166892.
  • Fortier, S., Labelle, D., Sina, A., Moreau, R. et Annabi, B. (2008). Silencing of the MT1-MMP/ G6PT axis suppresses calcium mobilization by sphingosine-1-phosphate in glioblastoma cells. FEBS Letters, 582(5), 799–804. http://dx.doi.org/10.1016/j.febslet.2008.01.061.
  • Annabi, B., Fortier, S., Touaibia, M., Lord-Dufour, S., Galipeau, J. et Roy, R. (2008). Tetra- and hexavalent mannosides inhibit the pro-apoptotic, anti-proliferative and cell surface clustering effects of concanavalin-A : Impact on MT1-MMP functions in marrow-derived mesenchymal stromal cells. Glycobiology, 18(2), 195–204. http://dx.doi.org/10.1093/glycob/cwm133.
  • Annabi, B., Rojas-Sutterlin, S., Laroche, M., Lacharnbre, M.P., Moumdjian, R. et Beliveau, R. (2008). The diet-derived sulforaphane inhibits matrix metalloproteinase-9-activated human brain microvascular endothelial cell migration and tubulogenesis. Molecular Nutrition and Food Research, 52(6), 692–700. http://dx.doi.org/10.1002/mnfr.200700434.
  • Annabi, B., Rojas-Sutterlin, S., Laflamme, C., Lachambre, M.-P., Rolland, Y., Sartelet, H. et Béliveau, R. (2008). Tumor Environment Dictates Medulloblastoma Cancer Stem Cell Expression and Invasive Phenotype. Molecular Cancer Research, 6(6), 907–916. http://dx.doi.org/10.1158/1541-7786.MCR-07-2184.
  • Annabi, B., Rafei, M., Wu, J.H., Lejeune, L., Francois, M. et Galipeau, J. (2007). A GMCSF & IL15 fusokine leads to paradoxical immunosuppression in vivo via asymmetrical JAK/STAT signaling through the IL15 receptor complex Blood. Blood, 109(5), 2234–2242. http://dx.doi.org/10.1182/blood-2006-07-037473.
  • Annabi, B., Perri, S.R. et Galipeau, J. (2007). Angiostatin inhibits monocyte/macrophage migration via disruption of actin cytoskeleton. FASEB Journal, 21(14), 3928–3936. http://dx.doi.org/10.1096/fj.07-8158com.
  • Annabi, B., Currie, J.-C., Moghrabi, A. et Beliveau, R. (2007). Inhibition of HuR and MMP-9 expression in macrophage-differentiated HL-60 myeloid leukemia cells by green tea polyphenol EGCg. Leukemia Research, 31(9), 1277–1284. http://dx.doi.org/10.1016/j.leukres.2006.10.001.
  • Ngameni, B., Touaibia, M., Belkaid, A., Ambassa, P., Watchueng, J., Patnam, R., Ngadjui, B. T., Annabi, B. et Roy, R. (2007). Inhibition of matrix metalloproteinase-2 secretion by chalcones from the twigs of Dorstenia barteri Bureau. ARKIVOC – Archive for Organic Chemistry, 9, 91–103. http://dx.doi.org/10.3998/ARK.5550190.0008.911.
  • Currie, J.-C., Fortier, S., Sina, A., Galipeau, J., Cao, J. et Annabi, B. (2007). MT1-MMP down-regulates the glucose 6-phosphate transporter expression in marrow stromal cells: A molecular link between pro-MMP-2 activation, chemotaxis, and cell survival. Journal of Biological Chemistry, 282(11), 8142–8149. http://dx.doi.org/10.1074/jbc.M610894200.
  • Belkaid, A., Fortier, S., Cao, J. et Annabi, B. (2007). Necrosis induction in glioblastoma cells reveals a new "bioswitch'' function for the MT1-MMP/G6PT signaling axis in proMMP-2 activation versus cell death decision. Neoplasia, 9(4), 332–340. http://dx.doi.org/10.1593/neo.07142.
  • Lamy, S., Ruiz, M.T., Wisniewski, J., Garde, S., Rabbani, S.A., Panchal, C., Wu, J.J. et Annabi, B. (2006). A prostate secretory protein94-derived synthetic peptide PCK3145 inhibits VEGF signalling in endothelial cells: Implication in tumor angiogenesis. International Journal of Cancer, 118(9), 2350–2358. http://dx.doi.org/10.1002/ijc.21615.
  • McLaughlin, N., Annabi, B., Lachambre, M.-P., Kim, K.S., Bahary, J.-P., Moumdjian, R. et Béliveau, R. (2006). Combined low dose ionizing radiation and green tea-derived epigallocatechin-3-gallate treatment induces human brain endothelial cells death. Journal of Neuro-Oncology, 80(2), 111–121. http://dx.doi.org/10.1007/s11060-006-9171-8.
  • Annabi, B., Currie, J.-C., Bouzeghrane, M., Dulude, H., Daigneault, L., Garde, S., Rabbani, S. A., Panchal, C., Wu, J.J. et Béliveau, R. (2006). Contribution of the 37-kDa laminin receptor precursor in the anti-metastatic PSP94-derived peptide PCK3145 cell surface binding. Biochemical and Biophysical Research Communications, 346(1), 358–366. http://dx.doi.org/10.1016/j.bbrc.2006.05.139.
  • Meriane, M., Duhamel, S., Lejeune, L., Galipeau, J. et Annabi, B. (2006). Cooperation of matrix metalloproteinases with the RhoA/Rho kinase and mitogen-activated protein kinase kinase-1/extracellular signal-regulated kinase signaling pathways is required for the sphingosine-1-phosphate-induced mobilization of marrow-derived stromal cells. Stem Cells, 24(11), 2557–2565. http://dx.doi.org/10.1634/stemcells.2006-0209.
  • Desrosiers, R.R., Rivard, M.-E., Grundy, P.E. et Annabi, B. (2006). Decrease in LDL receptor-related protein expression and function correlates with advanced stages of Wilms tumors. Pediatric Blood and Cancer, 46(1), 40–49. http://dx.doi.org/10.1002/pbc.20566.
  • Annabi, B., Ngameni, B., Touaibia, M., Patnam, R., Belkaid, A., Sonna, P., Bonaventure, T., Ngadjui, B. T. et Roy, R. (2006). Inhibition of MMP-2 secretion in glioblastoma cells with new and known furanocoumarins and chalcones from the twigs of Dorstenia turbinate. Phytochemistry, 67(23), 2573–2579. http://dx.doi.org/10.1016/j.phytochem.2006.09.017.
  • Belkaid, A., Copland, I.B., Massillon, D. et Annabi, B. (2006). Silencing of the human microsomal glucose-6-phosphate translocase induces glioma cell death: Potential new anticancer target for curcumin. FEBS Letters, 580(15), 3746–3752. http://dx.doi.org/10.1016/j.febslet.2006.05.071.
  • Belkaid, A., Currie, J.-C., Desgagnes, J. et Annabi, B. (2006). The chemopreventive properties of chlorogenic acid reveal a potential new role for the microsomal glucose-6-phosphate translocase in brain tumor progression. Cancer Cell International, 6(7), 1–12. http://dx.doi.org/10.1186/1475-2867-6-7.
  • McLaughlin, N., Annabi, B., Kim, K.S., Bahary, J.-P., Moumdjian, R. et Béliveau, R. (2006). The response to brain tumor-derived growth factors is altered in radioresistant human brain endothelial cells. Cancer Biology & Therapy, 5(11), 1539–1545. http://dx.doi.org/10.4161/cbt.5.11.3459.
  • McLaughlin, N., Annabi, B., Bouzeghrane, M., Temme, A., Bahary, J.-P., Moumdjian, R. et Beliveau, R. (2006). The Survivin-mediated radioresistant phenotype of glioblastomas is regulated by RhoA and inhibited by the green tea polyphenol (-)-epigallocatechin-3-gallate. Brain Research, 1071(1), 1–9. http://dx.doi.org/10.1016/j.brainres.2005.10.009.
  • Annabi, B., Bouzeghrane, M., Currie, J. C., Hawkins, R., Dulude, H., Daigneault, L., Ruiz, M., Wisniewski, J., Garde, S., Rabbani, S. A., Panchal, C., Wu, J. Z. J. et Beliveau, R. (2005). A PSP94-derived peptide PCK3145 inhibits MMP-9 secretion and triggers CD44 cell surface shedding: Implication in tumor metastasis. Clinical and Experimental Metastasis, 22(5), 429–439. http://dx.doi.org/10.1007/s10585-005-2669-1.
  • Demeule M., Annabi, B., Michaud-Levesque, J., Lamy, S. et Béliveau R. (2005). Dietary prevention of cancer : Anticancer and antiangiogenic properties of green tea polyphenols. Medicinal Chemistry Reviews, 2(1), 49–58. http://dx.doi.org/10.2174/1567203052997095.
  • Pilorget, A., Annabi, B., Bouzeghrane, F., Marvaldi, J., Luis, J. et Beliveau, R. (2005). Inhibition of angiogenic properties of brain endothelial cells by platelet-derived sphingosine-1-phosphate. Journal of Cerebral Blood Flow and Metabolism, 25(9), 1171–1182. http://dx.doi.org/10.1038/sj.jcbfm.9600117.
  • Perri, S.R., Nalbantoglu, J., Annabi, B., Koty, Z., Lejeune, L., François, M., Di Falco, M.R., Béliveau, R. et Galipeau, J. (2005). Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression. Cancer Research, 65(18), 8359–8365. http://dx.doi.org/10.1158/0008-5472.CAN-05-0508.
  • Annabi, B., Bouzeghrane, M., Moumdjian, R., Moghrabi, A. et Béliveau, R. (2005). Probing the infiltrating character of brain tumors: Inhibition of RhoA/ROK-mediated CD44 cell surface shedding from glioma cells by the green tea catechin EGCg. Journal of Neurochemistry, 94(4), 906–916. http://dx.doi.org/10.1111/j.1471-4159.2005.03256.x.
  • Gingras, D., Nyalendo, C., Di Tomasso, G., Annabi, B. et Béliveau, R. (2004). Activation of tissue plasminogen activator gene transcription by Neovastat, a multifunctional antiangiogenic agent. Biochemical and biophysical research communications, 320(1), 205–212. http://dx.doi.org/10.1016/j.bbrc.2004.05.151.
  • Demeule, M., Régina, A., Annabi, B., Bertrand, Y., Bojanowski, M.W. et Béliveau, R. (2004). Brain endothelial cells as pharmacological targets in brain tumors. Molecular Neurobiology, 30(2), 157–183. http://dx.doi.org/10.1385/MN:30:2:157.
  • Annabi, B., Thibeault, S., Moumdjian, R. et Béliveau, R. (2004). Hyaluronan cell surface binding is induced by type I collagen and regulated by caveolae in glioma cells. Journal of Biological Chemistry, 279(21), 21888–21896. http://dx.doi.org/10.1074/jbc.M313694200.
  • Annabi, B., Naud, E., Lee, Y.-T., Eliopoulos, N. et Galipeau, J. (2004). Vascular progenitors derived from murine bone marrow stromal cells are regulated by fibroblast growth factor and are avidly recruited by vascularizing tumors. Journal of Cellular Biochemistry, 91(6), 1146–1158. http://dx.doi.org/10.1002/jcb.10763.
  • Annabi, B., Lee, Y.-T., Turcotte, S., Naud, E., Desrosiers, R. R., Champagne, M., Eliopoulos, N., Galipeau, J. et Beliveau, R. (2003). Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation. Stem Cells, 21(3), 337–347. http://dx.doi.org/10.1634/stemcells.21-3-337.
  • Annabi, B., Thibeault, S., Lee, Y.T., Bousquet-Gagnon, N., Eliopoulos, N., Barrette, S., Galipeau, J. et Beliveau, R. (2003). Matrix metalloproteinase regulation of sphingosine-1-phosphate-induced angiogenic properties of bone marrow stromal cells. Experimental Hematology, 31(7), 640–649. http://dx.doi.org/10.1016/S0301-472X(03)00090-0.
  • Pilorget, A., Berthet, V., Luis, J., Moghrabi, A., Annabi, B. et Beliveau, R. (2003). Medulloblastoma cell invasion is inhibited by green tea (-) epigallocatechin-3-gallate. Journal of Cellular Biochemistry, 90(4), 745–755. http://dx.doi.org/10.1002/jcb.10667.
  • Laplante, A., Liu, D.Y., Demeule, M., Annabi, B., Murphy, G.F., Daloze, P., Chen, H.F. et Beliveau, R. (2003). Modulation of matrix gelatinases and metalloproteinase-activating process in acute kidney rejection. Transplant International, 16(4), 262–269. http://dx.doi.org/10.1007/s00147-002-0540-8.
  • Annabi, B., Lee, Y.-T., Martel, C., Pilorget, A., Bahary, J.-P. et Beliveau, R. (2003). Radiation induced-tubulogenesis in endothelial cells is antagonized by the antiangiogenic properties of green tea polyphenol (-) epigallocatechin-3-gallate. Cancer Biology & Therapy, 2(6), 642–649. Récupéré de https://www.tandfonline.com/doi/citedby/10.4161/cbt.2.6.529?scroll=top&needAccess=true.
  • Annabi, B., Shedid, D., Ghosn, P., Kenigsberg, R.L., Desrosiers, R.R., Bojanowski, M.W., Beaulieu, E., Nassif, E., Moumdjian, R. et Beliveau, R. (2002). Differential regulation of matrix metalloproteinase activities in abdominal aortic aneurysms. Journal of Vascular Surgery, 35(3), 539–546. http://dx.doi.org/10.1067/mva.2002.121124.
  • Demeule, M., Michaud-Levesque, J., Annabi, B., Gingras, D., Boivin, D., Jodoin, J., Lamy, S., Bertrand, Y. et Beliveau, R. (2002). Green Tea Catechins as Novel Antitumor and Antiangiogenic Compounds. Current Medicinal Chemistry -Anti-Cancer Agents, 2(4), 441–463. http://dx.doi.org/10.2174/1568011023353930.
  • Annabi, B., Lachambre, M.-P., Bousquet-Gagnon, N., Page, M., Gingras, D. et Beliveau, R. (2002). Green tea polyphenol (-)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells. Biochimica et Biophysica Acta – Molecular Cell Research, 1542(1-3), 209–220. http://dx.doi.org/10.1016/S0167-4889(01)00187-2.
  • Gingras, D., Bousquet-Gagnon, N., Langlois, S., Lachambre, M.-P., Annabi, B. et Béliveau, R. (2001). Activation of the extracellular signal-regulated protein kinase (ERK) cascade by membrane-type-1 matrix metalloproteinase (MT1-MMP). FEBS Letters, 507(2), 231–236. http://dx.doi.org/10.1016/S0014-5793(01)02985-4.
  • Annabi, B., Pilorget, A., Bousquet-Gagnon, N., Gingras, D. et Béliveau, R. (2001). Calmodulin inhibitors trigger the proteolytic processing of membrane type-1 matrix metalloproteinase, but not its shedding in glioblastoma cells. Biochemical Journal, 359(2), 325–333. http://dx.doi.org/10.1042/0264-6021:3590325.
  • Annabi, B., Lachambre, M.-P., Bousquet-Gagnon, N., Pagé, M., Gingras, D. et Béliveau, R. (2001). Localization of membrane-type 1 matrix metalloproteinase in caveolae membrane domains. The Biochemical Journal, 353(3), 547–553. Récupéré de https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1221600/pdf/11171051.pdf.
  • Mechin, M.C., Annabi, B., Pegorier, J.P. et Van de Werve, G. (2000). Ontogeny of the catalytic subunit and putative glucose-6-phosphate transporter proteins of the rat microsomal liver glucose-6-phosphatase system. Metabolism-Clinical and Experimental, 49(9), 1200–1203. http://dx.doi.org/10.1053/meta.2000.7714.
  • Gingras, D., Page, M., Annabi, B. et Beliveau, R. (2000). Rapid activation of matrix metalloproteinase-2 by glioma cells occurs through a posttranslational MT1-MMP-dependent mechanism. Biochimica et Biophysica Acta – Molecular Cell Research, 1497(3), 341–350. http://dx.doi.org/10.1016/S0167-4889(00)00071-9.
  • Lin, B., Annabi, B., Hiraiwa, H., Pan, C.-J. et Chou, J.Y. (1998). Cloning and characterization of cDNAs encoding a candidate glycogen storage disease type 1b protein in rodents. Journal of Biological Chemistry, 273(48), 31656–31660. http://dx.doi.org/10.1074/jbc.273.48.31656.
  • Annabi, B., Mandel, H., Fryman, M., Chou, J. Y., Hiraiwa, H., Mansfield, B. C., Lei, K.-J., Ubagai, T., Polymeropoulos, M. H., Moses, S. W., Parvari, R. et Hershkovitz, E. (1998). The gene for glycogen-storage disease type lb maps to chromosome 11q23. American Journal of Human Genetics, 62(2), 400–405. http://dx.doi.org/10.1086/301727.
  • Pan, C.-J., Lei, K.-J., Annabi, B., Hemrika, W. et Chou, J.Y. (1998). Transmembrane topology of glucose-6-phosphatase. Journal of Biological Chemistry, 273(11), 6144–6148. http://dx.doi.org/10.1074/jbc.273.11.6144.
  • Annabi, B. et Van De Werve, G. (1997). Evidence that the transit of glucose into liver microsomes is not required for functional glucose-6-phosphatase. Biochemical and Biophysical Research Communications, 236(3), 808–813. http://dx.doi.org/10.1006/bbrc.1997.6979.
  • St.-Denis, J.-F., Berteloot, A., Vidal, H., Annabi, B. et Van de Werve, G. (1995). Glucose transport and glucose 6-phosphate hydrolysis in intact rat liver microsomes. Journal of Biological Chemistry, 270(36), 21092–21097. http://dx.doi.org/10.1074/jbc.270.36.21092.
  • St-Denis, J.F., Annabi, B., Khoury, H. et Van de Werve, G. (1995). Histone II-A stimulates glucose-6-phosphatase and reveals mannose-6-phosphatase activities without permeabilization of liver microsomes. The Biochemical Journal, 310(1), 221–224. http://dx.doi.org/10.1042/BJ20020187.
  • Van de Werve, G., Annabi, B., Berteloot, A., St-Denis, J.-F. et Vidal, H. (1993). Le système glucose 6-phosphatase hépatique : composantes, propriétés cinétiques, régulation et déficit [The hepatic glucose-6-phosphatase system : components, kinetic properties, regulation and defects]. Médecine Sciences, 9(5), 577–582. Récupéré de https://www.ipubli.inserm.fr/handle/10608/2964.
  • Lavoie, L., Dimitrakoudis, D., Marette, A., Annabi, B., Klip, A., Vranic, M. et Werve, G.V.D. (1993). Opposite Effects of Hyperglycemia and Insulin Deficiency on Liver Glycogen Synthase Phosphatase Activity in the Diabetic Rat. Diabetes, 42(2), 363–366. http://dx.doi.org/10.2337/diab.42.2.363.
  • Garcia-Sainz, J.A., Alcantara-Hernandez, R., Robles-Flores, M., Torres-Marquez, M.E., Massillon, D., Annabi, B. et Van de Werne, G. (1992). Modulation by protein kinase-C of the hormonal responsiveness of hepatocytes from lean (Fa/fa?) and obese (fa/fa) Zucker Rats. Biochimica et Biophysica Acta, 1135(2), 221–225. http://dx.doi.org/10.1016/0167-4889(92)90140-7.
Chapitres de livre
  • Francisco Fernandez, M., Piloto-Ferrer, J. et Annabi, B. Targeting of cancer cell drug resistance phenotype and metastasis with Xanthium strumarium L. Extract. Dans B.A. Khan (dir.). Trends in Pharmaceutical Research and Development (vol. 3). Book Publisher International.
    Notes: (Sous presse)
  • Pratt, A., Coady, M. et Annabi B. (2016). Membrane type-1 matrix metalloproteinase-regulated autophagy : A role in brain cancer chemoresistance. Dans M.A. Hayat (dir.). Autophagy : Cancer, other pathologies, inflammation, immunity, infection, and aging (vol. 10, p. 213–230).
  • Annabi, B. (2009). Les cellules souches cancéreuses. Guide des tendances 2009 (p. 98–100). Isabelle Quentin Editeur.
Actes de colloque
  • González Suárez, N. et Annabi, B. (2021). Ciblage pharmacologique des cellules souches mésenchymateuses adipocytaires par l’EGCG : impact sur le contrôle oncogénique médié par STAT3 dans le phénotype invasif des cellules cancéreuses du sein triple négatif. Dans Journée de la recherche Gabriel L. Plaa en pharmacologie et physiologie, Université de Montréal.
  • Suarez N.G. et Annabi, B. (2021). EGCG inhibits triple negative breast cancer cells-mediated regulation of cancer-associated adipocytes. Dans 3e colloque du Centre d'excellence en recherche sur les maladies orphelines – Fondation Courtois (CERMO-FC).
  • González Suárez, N., Rodriguez Torres, S. et Annabi, B. (2021). EGCG targeting of adipogenesis reveals a STAT3-mediated paracrine oncogenic control of triple-negative breast cancer cell invasive phenotype [Résumé], Cancer Research, 81(13, suppl.), Abstract 2562. http://dx.doi.org/10.1158/1538-7445.AM2021-2562.
    Notes: Proceedings of the 112th American Association for Cancer Research annual meeting (Washington, DC, USA)
  • Demeule, M., Currie, J.C., Charfi, C., Larocque, A., Zgheib, A., Béliveau, R., Marsolais, C. et Annabi, B. (2021). Increasing potency of anticancer drugs through SORT1+ technology: A new targeted approach for the treatment of ovarian and endometrial cancers [Résumé], Cancer Research, 81(13, suppl.), Abstract 1439. http://dx.doi.org/10.1158/1538-7445.AM2021-1439.
    Notes: Proceedings of the 112th American Association for Cancer Research annual meeting (Washington, DC, USA)
  • Hajjar, R., Oliero, M., Cuisiniere, T., Fragoso, G., Calvé, A., Djediai, D., Annabi, B., Richard, C.S. et Santos, M.M. (2021). Inulin and galacto-oligosaccharides improve colonic anastomotic healing in mice undergoing colorectal surgery [Résumé], Gastroenterology, 160(6, suppl.), S-893. http://dx.doi.org/10.1016/S0016-5085(21)02866-3.
    Notes: Proceedings of the 2021 Keystone eSymposia : Harnessing the Microbiome for Disease Prevention and Therapy
  • Djediai, S. et Annabi, B. (2021). MT1-MMP cooperates with TGF-β receptor-mediated signaling to trigger SNAIL and induce epithelial-to-mesenchymal-like transition in U87 glioblastoma cells. Dans 3e colloque du Centre d'excellence en recherche sur les maladies orphelines – Fondation Courtois (CERMO-FC).
  • Rodriguez Torres, S., Gresseau, L. et Annabi, B. (2021). Targeting of the ovarian cancer stem cell phenotype by the green tea-derived catechin EGCG. Dans 3e colloque du Centre d'excellence en recherche sur les maladies orphelines – Fondation Courtois (CERMO-FC).
  • Marsolais, C., Currie, J.C., Demeule, M., Charfi, C., Larocque, A., Zgheib, A., Béliveau, R. et Annabi, B. (2021). TH1902, a docetaxel peptide-drug conjugate, shows pre-clinical efficacy in several Sortilin-positive (SORT1+) cancers [Résumé], Cancer Research, 81(13, suppl.), Abstract 1313. http://dx.doi.org/10.1158/1538-7445.AM2021-1313.
    Notes: Proceedings of the 112th American Association for Cancer Research annual meeting (Washington, DC, USA)
  • Marsolais, C., Charfi, C., Demeule, M., Currie, J.C., Larocque, A., Zgheib, A., Duquette, N., Béliveau, R. et Annabi, B. (2020). A novel Sortilin-targeted docetaxel peptide conjugate (TH1902), for the treatment of Sortilin-positive (SORT1+) triple-negative breast cancer. Dans Proceedings of the 111th American Association for Cancer Research annual meeting (San Diego, CA, USA).
  • Djediai, S., Torres, S.R. et Annabi, B. (2020). Diet-derived chemoprevention of epithelial-to-mesenchymal transition through targeting of MT1-MMP-mediated signaling in U87 brain cancer cells [Vidéo]. Dans 2e colloque du Centre d'excellence en recherche sur les maladies orphelines – Fondation Courtois (CERMO-FC). Récupéré de https://www.cermofc.uqam.ca/en/portfolio-item/brain-cancer/.
  • Sicard, A.A. et Annabi, B. (2020). Diet-derived gallated catechins prevent TGF-β-mediated epithelial-mesenchymal transition, cell migration and vasculogenic mimicry in chemosensitive ES-2 ovarian cancer cells [Résumé], The FASEB Journal, 34(S1):1-1. http://dx.doi.org/10.1096/fasebj.2020.34.s1.00293.
  • Ousji, O., Djediai, S., Annabi, B. et Sleno, L. (2020). In vitro metabolism of epigallocatechin gallate (EGCG) analogs by LC-HRMS/MS. Dans Proceedings of the 23rd Chemistry and Biochemistry Graduate Research Conference (Montreal, QC, Canada).
  • Hajjar, R., Oliero, M., Cuisiniere, T., Fragoso, G., Calvé, A., Annabi, B., Richard, C.S et Santos, M.M. (2020). Promotion of anastomotic healing in mice by modulating the gut microbiota with fermentable dietary fibers. Dans Proceedings of the 14th Canadian Society for Clinical Investigation (CSCI) and the Clinician Investigator Trainee Association of Canada (CITAC) annual meeting.
  • Demeule, M., Charfi, C., Currie, J.C., Larocque, A., Zgheib, A., Marsolais, C., Béliveau, R. et Annabi, B. (2020). Receptor-mediated chemotherapy using a new Docetaxel-peptide conjugate for Sortilin-positive triple-negative breast cancer [Résumé], Cancer Research, 80(4, suppl.), Abstract P3-10-07. http://dx.doi.org/10.1158/1538-7445.SABCS19-P3-10-07.
  • Demeule, M., Currie, J.C., Larocque, A., Zgheib, A., Béliveau, R., Marsolais, C. et Annabi, B. (2020). Sortilin receptor-mediated novel cancer therapy: A targeted approach to inhibit vasculogenic mimicry in ovarian and breast cancers [Résumé], Cancer Research, 80(16, suppl.), Abstract 685. http://dx.doi.org/10.1158/1538-7445.AM2020-685.
    Notes: Proceedings of the 111th American Association for Cancer Research annual meeting (San Diego, CA, USA)
  • González Suárez, N. et Annabi, B. (2020). Targeting adipogenesis with green tea derived catechins: An impact on the paracrine regulation of triple-negative breast cancer progression. Dans Proceedings of the 23rd Chemistry and Biochemistry Graduate Research Conference (Montreal, QC, Canada).
  • Suarez, N.G. et Annabi, B. (2020). Targeting adipogenesis with green tea derived catechins: An impact on the paracrine regulation of triple-negative breast cancer progression [Vidéo]. Dans 2e colloque du Centre d'excellence en recherche sur les maladies orphelines – Fondation Courtois (CERMO-FC). Récupéré de https://www.cermofc.uqam.ca/en/portfolio-item/triple-negative-breast-cancer/.
  • Annabi, B., Demeule, M., Currie, J.C., Larocque, A., Zgheib, A., Marsolais, C. et Béliveau, R. (2020). TH1901, a novel Curcumin-peptide conjugate for the treatment of Sortilin-positive (SORT1+) cancer [Résumé], Cancer Research, 80(16, suppl.), Abstract 6362. http://dx.doi.org/10.1158/1538-7445.AM2020-6362.
    Notes: Proceedings of the 111th American Association for Cancer Research annual meeting (San Diego, CA, USA)
  • Sicard, A.A., Dao, T. et Annabi, B. (2019). Gallated catechins prevent TGF-β-mediated epithelial-mesenchymal transition, cell migration and vasculogenic mimicry in chemosensitive ES-2 ovarian cancer cells. Dans 1er colloque du Centre d'excellence en recherche sur les maladies orphelines – Fondation Courtois (CERMO-FC).
  • Sicard, A.A., Dao, T., Gonzalez-Suarez, N. et Annabi, B. (2019). Gallated catechins prevent TGF-β-mediated epithelial-mesenchymal transition, cell migration and vasculogenic mimicry in chemosensitive ES-2 ovarian cancer cells. Dans Proceedings of the 61st Annual Meeting of the Club de Recherches Cliniques du Québec (St-Sauveur, QC, Canada).
  • Dao, T. et Annabi, B. (2019). Impact of diet-derived polyphenol EGCG on neurotensin response upon HL-60 promyelocytic leukemia cells acquisition of a macrophage-like phenotype. Dans Journée de la recherche Gabriel L. Plaa en pharmacologie et physiologie, Université de Montréal.
  • Dao, T., Syim, S., Mohammad-Ali, J. et Annabi, B. (2019). Impact of diet-derived polyphenol EGCG on neurotensin response upon HL-60 promyelocytic leukemia cells acquisition of a macrophage-like phenotype. Dans 1er colloque du Centre d'excellence en recherche sur les maladies orphelines – Fondation Courtois (CERMO-FC).
  • Dao, T. et Annabi, B. (2019). Impact of diet-derived polyphenol EGCG on neurotensin response upon HL-60 promyelocytic leukemia cells acquisition of a macrophage-like phenotype [Résumé], The FASEB Journal, 33(S1), lb96. http://dx.doi.org/10.1096/fasebj.2019.33.1_supplement.lb96.
  • Demeule, M., Currie, J.C., Larocque, A., Charfi, C., Kozelko, S., Zgheib, A., Béliveau, R. et Annabi, B. (2019). Increasing Potency and Safety of Anticancer Drugs through Sortilin Receptor-Mediated Cancer Therapy: A New Targeted Approach for the Treatment of Ovarian Cancer [Résumé], Journal of Clinical Oncology, 37(15, suppl.), e17068. http://dx.doi.org/10.1200/JCO.2019.37.15_suppl.e17068.
  • Demeule, M., Annabi, B., Currie, J.C., Larocque, A., Charfi, C. et Béliveau, R. (2019). New docetaxel-peptide conjugate for the treatment of sortilin-positive triple-negative breast cancer [Résumé], Journal of Clinical Oncology, 37(15, suppl.), e12556. http://dx.doi.org/10.1200/JCO.2019.37.15_suppl.e12556.
  • Piloto-Ferrer, J., Francisco Fernandez, M., Charfi, C., Gonzales, M.L., Lamy, S. et Annabi, B. (2019). Targeting ovarian cancer cell cytotoxic drug resistance phenotype with Xanthium strumarium L. extract. Dans 7th International Symposium of Pharmaceutical Sciences VII SICF : Chemistry of Natural Products (Cayos de Villa Clara, Cuba).
  • Djerir, D., Dao, T., Bourgault, S., Lamy, S., et Annabi, B. (2018). Biophysical evidence for differential gallated green tea catechins binding to membrane type-1 matrix metalloproteinase and its interactors. Dans Proceedings of the 14e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM (Ste-Adèle, QC, Canada).
  • Fernández, M.F., Charfi, C., Levert, A., Lamy, S. et Annabi, B. (2018). Ciblage du phénotype chimioresistant du cancer ovarien : Impact d’un extrait de Xanthium strumarium L. Dans Proceedings of the 14e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM (Ste-Adèle, QC, Canada).
  • Demeule, M., Currie, J.C., Larocque, A., Charfi, C., Béliveau, R., Vezeau, C. et Annabi, B. (2018). Increasing penetration of anticancer drugs through Sortilin receptor-mediated cancer therapy: A new targeted and personalized approach in the treatment of ovarian cancer. Dans Proceedings of the 14e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM (Ste-Adèle, QC, Canada).
  • Sheehy, S. et Annabi, B. (2017). A role for the membrane type-1 matrix metalloproteinase in the transcriptional regulation of carcinogen-induced inflammasome components [Résumé], Cancer Research, 77(13, suppl.), Abstract 2697. http://dx.doi.org/10.1158/1538-7445.AM2017-2697.
  • Demeule, M., Currie, J.C., Larocque, A., Charfi, C., Béliveau, R., Vezeau, C. et Annabi, B. (2017). Increasing penetration of anticancer drugs through sortilin receptor-mediated cancer therapy: A new targeted and personalized approach in the treatment of ovarian cancer [Résumé], Cancer Research, 77(13, suppl.), Abstract 5146. http://dx.doi.org/10.1158/1538-7445.AM2017-5146.
  • Zehtabi, F., Ispas-Szabo, P., Djerir, D., Sivakumaran, L., Annabi, B., Soulez, G., Mateescu, M.A. et Lerouge, S. (2017). Injectable chitosan hydrogels as embolizing and doxycycline delivery system for AAA treatment. Dans Proceedings of the 33rd annual meeting of the Canadian Biomaterial Society (Winnipeg, MB, Canada).
  • Vézina, A., Charfi, C. et Annabi, B. (2016). Adaptive mechanisms upon LRP1 repression: Impact on sphingosine-1-phosphate-mediated signalling and migration of brain endothelial cells [Résumé], Cancer Research, 76(14, suppl.), Abstract 3364. http://dx.doi.org/10.1158/1538-7445.AM2016-3364.
  • Muhire, E., Levert, A., Lamy, S. et Annabi, B. (2016). Caractérisation des propriétés antiprolifératives et anti-inflammatoires des baies et fleurs de sureau dans les cellules cancéreuses et endothéliales du cerveau. Dans 84e congrès de l’ACFAS (Montréal, QC, Canada).
  • Heddebault, N., Levert, A., Lamy, S. et Annabi, B. (2016). Effet des composés phytochimiques sur l’expression et la sécrétion d’adipokines dans un modèle de cellules souches adipeuses. Dans Proceedings of the 12e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM (Montreal, QC, Canada).
  • Muhire, E., Levert, A., Lamy, S. et Annabi, B. (2016). Impact des baies et fleurs de sureau sur la prolifération des cellules cancéreuses et endothéliales du cerveau. Dans Proceedings of the 12e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM (Montreal, QC, Canada).
  • Heddebaud, N., Levert, A., Lamy, S. et Annabi, B. (2016). Impact des composés phytochimiques sur les processus inflammatoires et angiogéniques impliqués dans le cancer et en relation avec l’obésité. Dans 84e congrès de l’ACFAS (Montréal, QC, Canada).
  • Ouanouki, A., Lamy, S. et Annabi, B. (2016). Les anthocyanidines inhibent l’expression de la périostine, un biomarqueur pro-invasif, induite par le TGF-β dans les glioblastomes. Dans Proceedings of the 12e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM (Montreal, QC, Canada).
  • Vézina, A., Charfi, C., Zgheib, A. et Annabi, B. (2016). Mécanismes adaptatifs et impact de LRP1 sur la migration des cellules endothéliales cérébrales en réponse à la sphingosine-1-phosphate. Dans 84e congrès de l’ACFAS (Montréal, QC, Canada).
  • Ouanouki, A., Muhire, E., Lamy, S. et Annabi, B. (2016). Pharmacological targeting of the TGF-beta induced epithelial-mesenchymal transition by anthocyanidins in glioblastoma [Résumé], Cancer Research, 76(14, suppl.), Abstract 4316. http://dx.doi.org/10.1158/1538-7445.AM2016-4316.
  • Bensiali-Hadaud, C., Levert, A., Lamy, S. et Annabi, B. (2016). Étude comparative de l’expression de biomarqueurs pro-inflammatoires dans 7 lignées cellulaires de glioblastomes. Dans 84e congrès de l’ACFAS (Montréal, QC, Canada).
  • Ouanouki, A., Lamy, S. et Annabi, B. (2016). Évaluation des effets des anthocyanidines sur la transition épithélio-mésenchymateuse : impact sur la périostine induite par le TGF-β dans les glioblastomes humains. Dans 84e congrès de l’ACFAS (Montréal, QC, Canada).
  • Burke-Nanni, S., Pratt, J., Beauchemin, D. et Annabi, B. (2015). Actin cytoskeleton disruption causes rapid LRP-1 internalization and degradation in a grade IV glioma cell model. Dans Proceedings of the 18th Chemistry and Biochemistry Graduate Research Conference, Concordia University (Montreal, QC, Canada).
  • Ouanouki, A., Lamy, S. et Annabi, B. (2015). Caractériser l’effet des anthocyanidines d’origine alimentaire sur le phenotype invasive des glioblastomes par le TGF-β. Dans Proceedings of the 1st Centre de Recherche Biomédicale BioMed-UQAM Research Retreat (Ste-Adèle, QC, Canada).
  • Ouanouki, A., Lamy, S. et Annabi, B. (2015). Ciblage pharmacologique par les anthocyanidines de la transition épithélio-mésenchymateuse induite par le TGF-b dans les glioblastomes. Dans Proceedings of the 57th Annual Meeting of the Club de Recherches Cliniques du Québec (St-Alexis des Monts, QC, Canada).
  • Burke-Nanni, S., Beauchemin, D., Pratt, J. et Annabi, B. (2015). Concanavalin-A triggers rapid intracellular trafficking and lysosomal compartimentation of the low-density lipoprotein receptor-related protein 1, a key mediator of brain tumour invasion. Dans Proceedings of the 1st Centre de Recherche Biomédicale BioMed-UQAM Research Retreat (Ste-Adèle, QC, Canada).
  • Gagné, P., Lamy, S. et Annabi, B. (2015). Effet comparatif des anthocyanidines sur l’action pro-angiogénique de la périostine dans l’endothélium vasculaire cerebral. Dans Proceedings of the 1st Centre de Recherche Biomédicale BioMed-UQAM Research Retreat (Ste-Adèle, QC, Canada).
  • Gagné, P., Lamy, S. et Annabi, B. (2015). Effet des anthocyanidines sur l’action proangiogénique de la périostine dans les cellules endothéliales cérébrales exposées à l’hypoxie. Dans Proceedings of the 57th Annual Meeting of the Club de Recherches Cliniques du Québec (St-Alexis des Monts, QC, Canada).
  • Pratt, J., Demeule, M., Haidara, K. et Annabi, B. (2015). Evidence for a MT1-MMP/LRP-1 expression balance that regulates Angiopep-2 internalization in glioblastoma : Possible impact in low-grade brain tumour therapy. Dans Proceedings of the 1st Centre de Recherche Biomédicale BioMed-UQAM Research Retreat (Ste-Adèle, QC, Canada).
  • Vézina, A., Sheehy, S., Demeule, M., Haidara, K., et Annabi, B. (2015). Evidence for differential Angiopep-2 sorting and upregulated cell surface binding/uptake processes between brain tumour and brain endothelial cells under hypoxic conditions. Dans Proceedings of the 1st Centre de Recherche Biomédicale BioMed-UQAM Research Retreat (Ste-Adèle, QC, Canada).
  • Charfi, C., Beauchemin, D., Vézina, A., Zgheib, A., Demeule, M., Haidara, K. et Annabi, B. (2015). Evidence for in vitro and in vivo adaptive mechanisms and increased angiopep-2 internalization upon low-density lipoprotein receptor-related protein 1 repression. Dans Proceedings of the 1st Centre de Recherche Biomédicale BioMed-UQAM Research Retreat (Ste-Adèle, QC, Canada).
  • Vézina, A., Sheehy, S., Pratt, J., Demeule, M., Haidara, K. et Annabi, B. (2015). Régulation des processus d’internalisation et de reconnaissance de l’Angiopep-2 en hypoxie dans les cellules tumorales cérébrales et les cellules microvasculaires endothéliales cérébrales. Dans Proceedings of the 57th Annual Meeting of the Club de Recherches Cliniques du Québec (St-Alexis des Monts, QC, Canada).
  • Sheehy, S. et Annabi, B. (2015). Régulation transcriptionnelle des marqueurs de l’inflammation : impact de la signalization intracellulaire médiée par MT1-MMP. Dans Proceedings of the 1st Centre de Recherche Biomédicale BioMed-UQAM Research Retreat (Ste-Adèle, QC, Canada).
  • Charfi, C., Beauchemin, D., Vézina, A., Zgheib, A., Demeule, M., Haidara, K. et Annabi, B. (2015). Répression du low-density lipoprotein receptor-related protein (LRP) 1 : impact sur l’internalisation de l’Angiopep-2. Dans Proceedings of the 57th Annual Meeting of the Club de Recherches Cliniques du Québec (St-Alexis des Monts, QC, Canada).
  • Beauchemin, D., Charfi, C., Demeule, M., Haidara, K. et Annabi, B. (2015). Étude des mécanismes d’endocytose d’Angiopep par des cellules endothéliales de la barriere hémoencéphalique et dans une lignée de glioblastoma humain. Dans Proceedings of the 1st Centre de Recherche Biomédicale BioMed-UQAM Research Retreat (Ste-Adèle, QC, Canada).
  • Wagner, M., Ohlund, L., Shiao, T.C., Vézina, A., Annabi, B., Roy, R. et Sleno, L. (2014). Analyse métabolomique différentielle par étiquetage isotopique et LC-HR-MS : application à l’étude du stress oxydatif de cellules HL60. Dans 82e congrès de l’ACFAS (Montréal, QC, Canada).
  • Lamy, S., Moldovan, P.L., Ben Saad, A. et Annabi, B. (2014). Biphasic effects of luteolin on interleukin-1 beta-induced cyclooxygenaee-2 expression in glioblastoma cells. Dans Proceedings of the 8th World Congress on Polyphenols Applications: ISANH Polyphenols (Lisbon, Portugal).
  • Benenemissi, I.H., Lamy, S., Poirier, J. et Annabi, B. (2014). Effet des catéchines du thé vert sur la régulation de la périostine : impact sur l’acquisition du phénotype métastasique des cellules tumorales cérébrales. Dans 82e congrès de l’ACFAS (Montréal, QC, Canada).
  • Benenemissi, I.H., Lamy, S., Poirier, J. et Annabi, B. (2014). Effet des catéchines du thé vert sur l’expression et la secretion de la périostine, un biomarqueur des metastases exprimé par les glioblastomes. Dans Proceedings of the 10e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM (Montreal, QC, Canada).
  • Ben Saad, A., Lamy, S., Zgheib, A. et Annabi, B. (2014). Effets anticancéreux du régime méditerranéen : rôle des composés phytochimiques de l’huile d’olive sur l’action de la cytokine pro-inflammatoire TNF-α dans les glioblastomes. Dans Proceedings of the 10e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM (Montreal, QC, Canada).
  • Pratt, J. et Annabi, B. (2014). Evidence of MTCBP-1 interaction with the cytoplasmic domain of MT1-MMP: Implications for the autophagy cell index of high grade glioblastoma. Dans Proceedings of 6th Science Day of GEPROM (Montréal, QC, Canada).
  • Pratt, J., Bourgault, S. et Annabi, B. (2014). Evidence of MTCBP-1 interaction with the cytoplasmic domain of MT1-MMP: Implications in the autophagy cell index of high grade glioblastoma. Dans Proceedings of the 10e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM (Montréal, QC, Canada).
  • Vézina, A. et Annabi, B. (2014). Impact de l’inflammation sur la ciliogénèse des cellules souches mésenchymateuses : contribution de la voie de signalisation NFκB. Dans 82e congrès de l’ACFAS (Montréal, QC, Canada).
  • Wagner, M., Ohlund, L., Shiao, T.C., Vézina, A., Annabi, B., Roy, R. et Slano, L. (2014). Investigation of oxidative stress in HL60 cells by quantitative metabolomics using isotope-labeling, differential analysis and RP-LC-HRMS. Dans Proceedings of the 10e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM (Montreal, QC, Canada).
  • Toufaïly, C. et Annabi, B. (2014). La Cavin-3 comme nouveau modulateur de la métalloprotéinase MMP-9 et inhibiteur de la migration des cellules de fibrosarcomes humains. Dans 82e congrès de l’ACFAS (Montréal, QC, Canada).
  • Pratt, J. et Annabi, B. (2014). Le domaine cytoplasmique de la métalloprotéase matricielle membranaire de type 1 (MT1-MMP) : un nouveau rôle dans l'induction de l'autophagie dans les glioblastomes. Dans 82e congrès de l’ACFAS (Montréal, QC, Canada).
  • Ouanouki, A., Lamy, S., Annabi, B. et Desrosiers, R.R. (2014). L’enzyme L-isoaspartyl (D-aspartyl) methyltransférase est nécessaire à l’angiogenèse des cellules endothéliales induite par le VEGF. Dans 82e congrès de l’ACFAS (Montréal, QC, Canada).
  • Vézina, A., Vaillancourt-Jean, E. et Annabi, B. (2014). NF-κB signaling regulates the cell surface expression of the primary cilium in tumor necrosis factor-α-treated mesenchymal stromal cells. Dans Proceedings of the 6th Science Day of GEPROM (Montreal, QC, Canada).
  • Vézina, A. et Annabi, B. (2014). Régulation transcriptionnelle de G6PT : un rôle métabolique dans la cancérogénèse des cellules tumorales cérébrales. Dans Proceedings of the 10e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM (Montréal, QC, Canada).
  • Vézina, A. et Annabi, B. (2014). Régulation transcriptionnelle de G6PT : un rôle métabolique dans la cancérogénèse des cellules tumorales cérébrales? Dans 82e congrès de l’ACFAS (Montréal, QC, Canada).
  • Pratt, J. et Annabi, B. (2013). Concanavalin-A-induced expression of BNIP3 autophagy biomarker requires a JAK2/STAT3 and MT1-MMP signaling interplay in U87 glioblastoma cells. Dans Proceedings of the 13th Annual McGill Biomedical Graduate Conference (Montreal, QC, Canada).
  • Wagner, M., Boukhedimi, Y., Ohlund, L., Shiao, T.C., Vézina, A., Annabi, B., Parker, A.P., Jenna, S., Roy, R. et Sleno, L. (2013). Differential analysis for quantitative metabolomics using isotope-labeling and LC-HRMS: data processing strategies, Journal of The American Society for Mass Spectrometry, 24(S1), 131.
  • Moldovan, P.L., Lamy, S., Ben Saad, A. et Annabi, B. (2013). Effet de la lutéoline sur l’expression de la COX-2, un modulateur pro-inflammatoire induit par l’IL-1 dans les glioblastomes. Dans Proceedings of the 9e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM (Trois-Rivières, QC, Canada).
  • Ben Saad, A., Lamy, S., Zgheib, A., Moldovan, P.L. et Annabi, B. (2013). Effets anticancéreux de l’huile d’olive : inhibition de l’action du TNF-α, une cytokine proinflammatoire dans le développement des glioblastomes. Dans Proceedings of the 9e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM (Trois-Rivieres, QC, Canada).
  • Chokor, R., Lamy, S. et Annabi, B. (2013). Impact de l’EGCG, un polyphénol du thé vert, sur la réponse à la sphingosine-1-phosphate dans un modèle de la différenciation Monocyte/Macrophage. Dans Proceedings of the 9e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM (Trois-Rivières, QC, Canada).
  • Desjarlais, M., Pratt, J. et Annabi, B. (2013). Non-antibiotic effects of the tetracycline derivative minocycline require MT1-MMP in concanavalin-A-induced autophagy and inflammation in human hepatoma cells. Dans Proceedings of the 13th Annual McGill Biomedical Graduate Conference (Montreal, QC, Canada).
  • Desjarlais, M., Pratt, J. et Annabi, B. (2013). Non-antibiotic effects of the tetracycline derivative minocycline require MT1-MMP in concanavalin-A-induced autophagy and inflammation in human hepatoma cells. Dans Proceedings of the 9e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM (Trois-Rivières, QC, Canada).
  • Pratt, J. et Annabi, B. (2013). Nouvelle fonction de MT1-MMP dans l’induction de l’autophagie dans les glioblastomes. Dans Proceedings of the 9e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM (Trois-Rivieres, QC, Canada).
  • Vézina, A. et Annabi, B. (2013). Signal transducing functions from the membrane bound matrix metalloproteinase MT1-MMP impact on the glucose-6-phosphate translocase transcriptional regulation. Dans Proceedings of the 13th Annual McGill Biomedical Graduate Conference (Montreal, QC, Canada).
  • Vézina, A., Levros, L.C. Jr. et Annabi, B. (2013). Signal transducing functions from the membrane bound matrix metalloproteinase MT1-MMP impact on the glucose-6-phosphate translocase transcriptional regulation. Dans Proceedings of the 9e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM (Trois-Rivieres, QC, Canada).
  • Zgheib, A., Lamy, S. et Annabi, B. (2013). Transcriptional inhibition of colony stimulating factors-2 and -3 by green tea polyphenol EGCG requires sequential targeting of MT1-MMP-mediated Src and JAK/STAT3. Dans Proceedings of the 9e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM (Trois-Rivières, QC, Canada).
  • Zgheib, A., Lamy, S. et Annabi, B. (2013). Transcriptional inhibition of colony stimulating factors-2 and -3 by green tea polyphenol EGCG requires sequential targeting of MT1-MMP-mediated Src and JAK/STAT3 signalling in Concanavalin-A-activated mesenchymal stromal cells. Dans Proceedings of the 13th Annual McGill Biomedical Graduate Conference (Montréal, QC, Canada).
  • Pratt, J. et Annabi, B. (2012). A membrane-anchored matrix metalloproteinase MT1-MMP signals Concanavalin-A-induced autophagy in U87 glioblastoma cells. Dans Proceedings of 4th Science Day of GEPROM (Montreal, QC, Canada).
  • Pratt, J. et Annabi, B. (2012). A role for the intracellular domain of MT1-MMP in Concanavalin-A-induced autophagy in U87 glioblastoma cells. Dans Proceedings of the 12th Annual McGill Biomedical Graduate Conference (Montreal, QC, Canada).
  • Vézina, A. et Annabi, B. (2012). Ciblage pharmacologique et évaluation in vitro de l’impact chimiopréventif de l’EGCG : une question de différenciation cellulaire dans la neuroinflammation? Dans Proceedings of the 8e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM.
  • Pratt, J. et Annabi, B. (2012). Concanavalin-A-induced autophagy biomarkers requires membrane type-1 matrix metalloproteinase intracellular signalling in glioblastoma cells. Dans Proceedings of the 8e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM.
  • Vézina, A., Chokor, R. et Annabi, B. (2012). Expression of the 67kDa Laminin Receptor dictates the targeting efficacy of (-)-epigallocatechin-3-gallate during monocytic/macrophagic differentiation of human promyelocytic leukemia cells. Dans Proceedings of the 4th Science Day of GEPROM (Montreal, QC, Canada).
  • Ohlund, L.B., Plante, V., Vézina, A., Shiao, T.C., Roy, R., Annabi, B. et Sleno, L. (2012). Isotope-labeled differential profiling of amine-containing metabolites in cultured cells by high resolution mass spectrometry. Dans Proceedings of the 4th Annual Conferences of The Association for Mass Spectrometry : Applications to the Clinical Laboratory (San Diego, CA, USA).
  • Wagner, M., Ohlund, L., Plante, V., Vézina, A., Shiao, T.C., Roy, R., Annabi, B. et Sleno, L. (2012). Isotope-labeled differential profiling of amine-containing metabolites in cultured cells by high resolution mass spectrometry. Dans Proceedings of the 4th PharmaQAM annual meeting (Montreal, QC, Canada).
  • Akla, N., Pratt, J. et Annabi, B. (2012). La métalloprotéinase membranaire de type-1 régule le phénotype pro-inflammatoire des cellules souches mésenchymateuses via une voie de signalisation STAT3-dépendante. Dans Proceedings of the 8e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM.
  • Vézina, A. et Annabi, B. (2012). Monocytic/macrophagic differentiation status of human promyelocytic leukemia cells dictates targeting efficacy of NF-kappaB downstream gene products. Dans Proceedings of the 12th Annual McGill Biomedical Graduate Conference (Montreal, QC, Canada).
  • Vézina, A. et Annabi, B. (2012). Monocytic/macrophagic differentiation status of human promyelocytic leukemia cells dictates targeting efficacy of NF-kappaB downstream gene products [Résumé], Cancer Research, 72(8, suppl.), Abstract 1976. http://dx.doi.org/10.1158/1538-7445.AM2012-1976.
  • Vaillancourt-Jean, E., Annabi, B. et Béliveau, R. (2012). MT1-MMP expression level status dictates the in vitro anti-inflammatory action of lupeol in medulloblastoma cells. Dans Proceedings of the 8e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM.
  • Desjarlais, M., Pratt, J. et Annabi, B. (2012). Propriétés anti-tumorales et anti-inflammatoires de la minocycline : nouveau mécanisme d’action dans l’inhibition de l’autophagie des cellules d’hépatomes humains. Dans Proceedings of the 8e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM.
  • Lacombe, C., Beauchemin, D., Annabi, B. et Van Themsche, C. (2012). Regulation of PAX2 expression/activity by hypoxia and EGF in breast cancer cells [Résumé], Cancer Research, 72(8, suppl.), Abstract 3067. http://dx.doi.org/10.1158/1538-7445.AM2012-3067.
  • Ohlund, L.B., Plante, V., Shiao, T.C., Vézina, A., Annabi, B., Roy, R. et Sleno, L. (2012). Relative quantitation of amine-containing metabolites in human cells using isotope-labeled derivatization and high resolution quadrupole time of flight mass spectrometry. Dans Proceedings of the 60th ASMS Conference on Mass Spectrometry and Allied Topics (Vancouver, BC, Canada).
  • Annabi, B., Lord-Dufour, S., Vézina, A., Lamy, S. et Béliveau, R. (2012). Resveratrol targeting of carcinogen-induced brain endothelial cell inflammation biomarkers MMP-9 and COX-2 is Sirt1-independent [Résumé], Cancer Research, 72(8, suppl.), Abstract 4737. http://dx.doi.org/10.1158/1538-7445.AM2012-4737.
  • Lacombe, C., Beauchemin, D., Annabi, B. et Van Themsche, C. (2012). Régulation de l’expression/activité de PAX2 par le facteur EGF et par l’hypoxie dans les cellules du cancer du sein MCF-7. Dans Proceedings of the 8e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM.
  • Pratt, J. et Annabi, B. (2011). A role for the intracellular domain of MT1-MMP in Concanavalin-A-induced autophagy in U87 glioblastoma cells. Dans Proceedings of the Zing Autophagy Conference (Xcaret, Mexico).
  • Proulx-Bonneau, S., Guezguez, A., Noel, J. et Annabi, B. (2011). Adaptation des cellules souches mésenchymateuses à l’hypoxie : identification de la protéine adaptatrice 3BP2 comme nouvelle cible de HIF-1α. Dans Proceedings of the 53rd Annual Meeting of the Club de Recherches Cliniques du Québec (Saint-Adèle, QC, Canada).
  • Vézina, A. et Annabi, B. (2011). Adaptation métabolique et acquisition d’un phénotype inflammatoire et invasif caractérisent la différenciation des cellules promyélocytaires HL-60 en macrophages. Dans Proceedings of the 7e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM.
  • Proulx-Bonneau, S., Noel, J. et Annabi, B. (2011). Contrôle hypoxique de la ciliogénèse par les secreted frizzled-related proteins dans les cellules souches mésenchymateuses. Dans Proceedings of the 53rd Annual Meeting of the Club de Recherches Cliniques du Québec (Saint-Adèle, QC, Canada).
  • Lacombe, C., Beauchemin, D., Annabi, B. et Van Themsche, C. (2011). Est-ce que l’hypoxie et le facteur EGF régulent la protein PAX2 dans les cellules du cancer du sein? Dans Proceedings of the 7e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM.
  • Vaillancourt, J., Annabi, B. et Béliveau, R. (2011). Inhibition de la sécrétion de la MMP-9 médiée au PMA par le propranolol, un inhibiteur pharmacologique des récepteurs β-adrénergiques. Dans Proceedings of the 7e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM.
  • Ohlund, L.B., Plante, V., Belainine, H., Shiao, T.C., Proulx-Bonneau, S., Annabi, B., Roy, R. et Sleno, L. (2011). Isotope-labeled differential profiling of amine-containing metabolites in mesenchymal stem cells under hypoxic conditions, Journal of the American Society for Mass Spectrometry, 22(S1), 68.
  • Ohlund, L.B., Plante, V., Belainine, H., Shiao, T.C., Proulx-Bonneau, S., Annabi, B., Roy, R. et Sleno, L. (2011). Isotope-labeled differential profiling of amine-containing metabolites in mesenchymal stem cells under hypoxic conditions. Dans Proceedings of the Montreal Post-ASMS Mass Spectrometry Annual Symposium (Montreal, QC, Canada).
  • Peiro, S. et Annabi, B. (2011). Le transporteur microsomal du glucose-6-phosphate : un nouveau rôle dans l’homéostasie métabolique et la survie cellulaire. Dans Proceedings of the 7e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM.
  • Tahanian, E., Peiro, S. et Annabi, B. (2011). Low intracellular ATP levels exacerbate carcinogen-induced inflammatory stress response and inhibit in vitro tubulogenesis in human brain endothelial cells. Dans Proceedings of the 7e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM.
  • Pratt, J., Proulx-Bonneau, S., Noel, J. et Annabi, B. (2011). L’induction du stress endoplasmique par la métalloprotéase matricielle MT1-MMP : un rôle dans la régulation de l’apoptose des cellules de glioblastome humain. Dans Proceedings of the 53rd Annual Meeting of the Club de Recherches Cliniques du Québec (Saint-Adèle, QC, Canada).
  • Proulx-Bonneau, S. et Annabi, B. (2011). Secreted Frizzled-related proteins control the hypoxic disruption of the primary cilium in bone marrow-derived mesenchymal stromal cells. Dans Proceedings of the 7e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM.
  • Proulx-Bonneau, S., Shiao, T.C., Sallam, L.M., Roy, R. et Annabi, B. (2010). A small library of glucose analogues bearing hydrophobic triazole aglycones antagonizes carcinogen-mediated signaling in human brain endothelial cells. Dans Proceedings of the 2nd PharmaQAM annual meeting (Montreal, QC, Canada).
  • Guezguez, A. et Annabi, B. (2010). Adaptation des cellules souches mésenchymateuses à l’hypoxie : identification de la protéine adaptatrice 3BP2 comme nouvelle cible de HIF-1α. Dans Proceedings of the 6e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM.
  • Lord-Dufour, S., Khosla, C. et Annabi, B. (2010). Evidence for Transcriptional Regulation of the Glucose-6-Phosphate Transporter by HIF-1alpha: Targeting G6PT with Mumbaistatin Analogs in Hypoxic Mesenchymal Stromal Cells [Résumé], Cell Journal (Yakhteh), 12(suppl. 1), 35-36. Récupéré de https://celljournal.org/journal/article/abstract/3871.
  • Doumit, J., Annabi, B. et Béliveau, R. (2010). Expression différentielle et fonctionnelle de la famille des LRP dans les cellules CD133(+) de médulloblastomes. Dans Proceedings of the 78e congrès de l’ACFAS (Montreal, QC, Canada).
  • Tahanian, E., Roy, R. et Annabi, B. (2010). Les analogues de la mumbaistatin inhibent la tubulogénèse et la migration des cellules endothéliales cérébrales. Dans Proceedings of the 78e congrès de l’ACFAS (Montreal, QC, Canada).
  • Sina, A. et Annabi, B. (2010). L’actinonine, un inhibiteur de l’aminopeptidase N/CD13, cible MT1-MMP dans les cellules de glioblastome, Annales de Biologie Clinique, 68(2), 173-211.
  • Proulx-Bonneau, S. et Annabi, B. (2010). L’induction du stress endoplasmique par MT1-MMP : un rôle dans le contrôle métabolique et dans le processus invasif des cellules tumorales. Dans Proceedings of the 6e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM.
  • Proulx-Bonneau, S. et Annabi, B. (2010). Mise en évidence d’un nouvel axe de signalisation MT1-MMP/COX-2 dans la régulation du phénotype inflammatoire des glioblastomes. Dans Proceedings of the 78e congrès de l’ACFAS (Montreal, QC, Canada).
  • Tahanian, E., et Annabi, B. (2010). Mise en évidence pharmacologique d’un rôle du transporteur microsomal du glucose-6-phosphate (G6PT) dans la tubulogénèse des cellules endothéliales cérébrales. Dans Proceedings of the 6e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM.
  • Kuss, S., Beaulieu, I., Mezour, M.A., Cornut, R., Annabi, B. et Mauzeroll, J. (2010). Multidrug resistance assessment using biological scanning electrochemical microscopy. Dans Proceedings of the 37th Northeast Regional Meeting of the American Chemical Society (Potsdam, NY, USA).
  • Sina, A. et Annabi, B. (2010). New membrane bound matrix metalloproteinase-mediated signaling functions in cyclooxygenase-2 expression require IKKgamma/NFkB-dependent pathway. Dans Proceedings of the 3rd Science Day of GEPROM (Montreal, QC, Canada).
  • Plouffe, K., Annabi, B. et Béliveau, R. (2010). Phénotype invasif et réponse aux facteurs plaquettaires des cellules souches cancéreuses CD133(+) isolées de glioblastomes. Dans Proceedings of the 78e congrès de l’ACFAS (Montreal, QC, Canada).
  • Sina, A. et Annabi, B. (2010). The lectin concanavalin-A induces cyclooxygenase-2 expression through an IKKgamma/NFkB-dependent pathway in U87 glioblastoma cells. Dans Proceedings of the 6e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM.
  • Sina, A., Proulx-Bonneau, S. et Annabi, B. (2010). The lectin concanavalin-A induces cyclooxygenase-2 expression through an IKKgamma/NFkB-dependent pathway in U87 glioblastoma cells [Résumé], Cancer Research, 70(8, suppl.), Abstract 4027. http://dx.doi.org/10.1158/1538-7445.AM10-4027.
  • Proulx-Bonneau, S. et Annabi, B. (2010). Vesicular trafficking evidences for a role of MT1-MMP in ER-stress and regulation of cancer cell invasive phenotype. Dans Proceedings of the 3rd Science Day of GEPROM (Montreal, QC, Canada).
  • Sina, A. et Annabi, B. (2009). Cell-based evidence for aminopeptidase N/CD13 inhibitor actinonin targeting of MT1-MMP-mediated proMMP-2 activation. Dans Proceedings of the 1st PharmaQAM annual meeting (Montreal, QC, Canada).
  • Sina, A. et Annabi, B. (2009). Ciblage du potentiel invasif des cellules de glioblastomes à l’aide de l’actinonine, un inhibiteur de l’aminopeptidase N/CD13. Dans Proceedings of the 5e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM.
  • Hubner, S., Annabi, B. et Mauzeroll, J. (2009). Effect of FcMeOH on intracellular regulatory substances in HeLa cells and its application in scanning electrochemical microscopy. Dans Proceedings of the 5th annual McGill Biophysical Chemistry Symposium (Montreal, QC, Canada).
  • Hubner, S., Annabi, B. et Mauzeroll, J. (2009). Effect of FcMeOH on intracellular regulatory substances in HeLa cells and its application in scanning electrochemical microscopy. Dans Proceedings of the 1st PharmaQAM annual meeting (Montreal, QC, Canada).
  • Laflamme, C., Annabi, B. et Béliveau, R. (2009). High COX-2 expression is a signature of CD133+ U87 glioblastoma stem cells and requires the MT1-MMP/NF-kB signaling axis. Dans Proceedings of the 5th Stem Cell Research & Therapeutics annual meeting (Boston, MA, USA).
  • Lord-Dufour, S., Khosla, C., Rassart, E. et Annabi, B. (2009). Metabolic flexibility and targeting of hypoxic marrow-derived mesenchymal stromal cells with mumbaistatin analogs. Dans Proceedings of the 1st PharmaQAM annual meeting (Montreal, QC, Canada).
  • Plouffe, K., Annabi, B. et Béliveau, R. (2009). Phénotype invasif et réponse aux facteurs plaquettaires des cellules souches cancéreuses CD133(+). Dans Proceedings of the 5e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM.
  • Papadopoulos, A., Shiao, T.C., Chabre, Y., Laflamme, C., Annabi, B. et Roy, R. (2009). Synthesis and biological evaluation of mannodendrimers as potential ligands of pathogenic E. coli. Dans Proceedings of the 1st PharmaQAM annual meeting (Montreal, QC, Canada).
  • Guérard, C., Sina, A., Racicot, L., Sabot, C., Annabi, B. et Canési, S. (2009). Synthèses totales et propriétés anticancéreuses d’alcaloides bioactifs de la famille des Amaryllidacées. Dans Proceedings of the 1st PharmaQAM annual meeting (Montreal, QC, Canada).
  • Lord-Dufour, S., Khosla, C., Galipeau, J. et Annabi, B. (2009). Targeting hypoxic marrow-derived mesenchymal stromal cells with mumbaistatin analogs: Evidence for a glucose-6-phosphate transporter gene transcriptional regulation by HIF-1α. Dans Proceedings of the 5th Stem Cell Research & Therapeutics annual meeting (Boston, MA, USA).
  • Hubner, S., Beaulieu, I., Mezour, M.A., Annabi, B. et Mauzeroll, J. (2009). The effect of ferrocene methanol on intracellular glutathione and its application to biological scanning electrochemical microscopy. Dans Proceedings of the 5th annual CSACS symposium (Sherbrooke, QC, Canada).
  • Laflamme, C., Annabi, B. et Béliveau, R. (2009). Un axe de signalisation MT1-MMP/NF-kB régule l’expression de COX-2 dans les cellules souches cancéreuses CD133(+) de glioblastoma. Dans Proceedings of the 5e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM.
  • Fortier, S., Labelle, D., Moreau, R. et Annabi, B. (2008). A functional MT1-MMP / glucose-6-phosphate transporter axis is required for calcium mobilization by sphingosine-1-phosphate in glioblastoma cells. Dans Proceedings of the 4e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM.
  • Fortier, S., Lord-Dufour, S., Sina, A. et Annabi, B. (2008). A functional MT1-MMP / glucose-6-phosphate transporter axis is required for calcium mobilization by sphingosine-1-phosphate in glioblastoma cells [Résumé], Cancer Research, 68(9, suppl.), Abstract 3524. Récupéré de https://cancerres.aacrjournals.org/content/68/9_Supplement/3524.
  • Annabi, B., Cajina Herrera, M.M., Falardeau, P. et Gourdeau, H. (2008). A structurally novel farnesylated dibenzodiazepinone, ECO-4601, inhibits wild-type and mutant epidermal growth factor receptor (EGFRvIII) glioma cell migration [Résumé], Cancer Research, 68(9, suppl.), Abstract 1485. Récupéré de https://cancerres.aacrjournals.org/content/68/9_Supplement/1485.
  • Rojas-Sutterlin, S., Lachambre, M.P., Annabi, B. et Béliveau, R. (2008). Les effets anti-cancérigènes du sulforaphane du brocoli ciblent les fonctions de MMP-9 dans les cellules endothéliales cérébrales humaines. Dans 76e congrès de l’ACFAS (Québec, QC, Canada).
  • Rojas-Sutterlin, S., Annabi, B. et Béliveau, R. (2008). Les propriétés anti-angiogéniques du sulforaphane ciblent la migration et la tubulogénèse des cellules endothéliales cérébrales humaines. Dans Proceedings of the 4e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM.
  • Laflamme, C., Rojas-Sutterlin, S., Annabi, B. et Béliveau, R. (2008). L’acquisition du phénotype invasif des cellules souches cancéreuses CD133(+) dérivées de médulloblastomes requiert MT1-MMP et MMP-9. Dans Proceedings of the 4e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM.
  • Laflamme, C., Rojas-Sutterlin, S., Annabi, B. et Béliveau, R. (2008). L’acquisition du phénotype invasif des cellules souches cancéreuses CD133(+) dérivées de tumeurs cérébrales requiert MT1-MMP et MMP-9. Dans 76e congrès de l’ACFAS (Québec, QC, Canada).
  • Fortier, S. et Annabi, B. (2008). Mobilisation des cellules souches stromales en réponse aux facteurs de croissances tumoraux : identification d’un nouvel axe de signalisation MT1-MMP/G6PT. Dans 76e congrès de l’ACFAS (Québec, QC, Canada).
  • Annabi, B., Béliveau, R., Breau, L., Canesi, S., Chapdelaine, D., Claverie, J., Desrosiers, R., Jenna, S., Marcotte, I., Mateescu, M.A., Mauzeroll, J., Paquin, J., Sirois, S. et Roy, R. (2008). PharmaQÀM: A new academic pharmaceutical platform at UQAM [Résumé], Biochemistry and Cell Biology, 86(2), 203-204. http://dx.doi.org/10.1139/o07-906.
    Notes: Abstracts of the 50th annual CSBMCB meeting – Systems and Chemical Biology
  • Lord-Dufour, S. et Annabi, B. (2008). Régulation du transporteur du glucose-6-phosphate par HIF-1α : impact sur la survie et la mobilisation des cellules souches mésenchymateuses en hypoxie. Dans Proceedings of the 4e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM.
  • Annabi, B., Laflamme, C., Rojas-Sutterlin, S., Lachambre, M.P. et Béliveau, R. (2008). Tumour tissue environment dictates CD133(+) medulloblastoma-derived cancer stem cells development and invasive phenotype: A role for MT1-MMP and MMP-9 [Résumé], Cancer Research, 68(9, suppl.), Abstract 1144. Récupéré de https://cancerres.aacrjournals.org/content/68/9_Supplement/1144.
  • McLaughlin, N., Annabi, B. et Béliveau, R. (2007). Altération de la réponse des cellules endothéliales cérébrales radiorésistantes aux facteurs de croissances tumoraux [Résumé], Neurochirurgie, 53(5), 426. http://dx.doi.org/10.1016/j.neuchi.2007.09.042.
  • Fortier, S., Lord-Dufour, S. et Annabi, B. (2007). Contribution d’un transporteur microsomal de glucose-6-phosphate dans la régulation de la survie et de la mobilisation des cellules souches stromales en réponse aux facteurs der croissances tumoraux. Dans Proceedings of the 5e Congrès Armand Frappier-INRS (Orford, QC, Canada).
  • Copland, I.B., Jolicoeur, M.E., Gillis, M.A., Cuerquis, J., Eliopoulos, N., Annabi, B., Calderone, A., Tanguay, J.F., Ducharme, A. et Galipeau, J. (2007). Erythropoietin (Epo) Secreting Mesenchymal Stromal Cells and Autocrine Signalling Via the Epo Receptor. A Novel, Cell-Based Paracrine Epo Delivery System for Cardiovascular Therapy [Résumé], Blood, 110(11), 1198. http://dx.doi.org/10.1182/blood.V110.11.1198.1198.
  • Rojas-Sutterlin, S., Annabi, B. et Béliveau, R. (2007). Le sulforaphane, un isothiocyanate du brocoli, inhibe l’invasion tumorale en ciblant la MMP-9. Dans Proceedings of the 5e Congrès Armand Frappier-INRS (Orford, QC, Canada).
  • Rojas-Sutterlin, S., Annabi, B. et Béliveau, R. (2007). Le sulforaphane, un isothiocyanate du brocoli, inhibe l’invasion tumorale en ciblant la MMP-9. Dans Proceedings of the 3e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM.
  • Fortier, S., Currie, J.C. et Annabi, B. (2007). Un nouvel axe de signalisation MT1-MMP/G6PT régule la survie et la mobilisation des cellules souches stromales en réponse aux facteurs de croissances tumoraux. Dans Proceedings of the 3e Colloque Annuel du Centre de Recherche Biomédicale BioMed-UQAM.
  • Laflamme, C., Rojas-Sutterlin, S., Annabi, B. et Béliveau, R. (2007). Un rôle pour MT1-MMP et MMP-9 dans l’acquisition d’un phénotype invasif des cellules souches cancéreuses CD133(+) dérivées de tumeurs cérébrales. Dans Proceedings of the 5e Congrès Armand Frappier-INRS (Orford, QC, Canada).
  • McLaughlin, N., Annabi, B., Bahary, J.P., Moumdjian, R. et Béliveau, R. (2006). Combined green tea-derived epigallocatechin-3-gallate and low dose ionizing radiation treatments induce necrosis in human brain endothelial cells [Résumé], The Canadian Journal of Neurological Sciences, 33(S1), S30. http://dx.doi.org/10.1017/S0317167100017042.
  • Panchal, C., Béliveau, R., Annabi, B., Slovin, S.F., Scher, H., Wu, J.J., Daigneault, L., Garde, S. et Dulude, H. (2006). Evaluation of a prostate secretory protein94-derived synthetic peptide PCK3145 in patients with castrate metastatic prostate cancer: Inhibition of VEGF signaling, MMP-9 secretion and CD44-mediated MMP-9 cell surface binding. Dans Proceedings of the 2nd International Congress – Natural Peptides to Drugs (Zermatt, Switzerland) Journal of Peptide Science.
  • Shukeir, N., Garde, S., Arakelian, A., Chen, G., Annabi, B., Béliveau, R., Wu, J.J., Panchal, C. et Rabbani, S.A. (2006). Inhibition of angiogenesis and MMP-9 expression by PCK3145 is mediated through targeting of the Akt signaling pathway [Résumé], Cancer Research, 66(8, suppl.), 1026, Abstract 4369. Récupéré de https://cancerres.aacrjournals.org/content/66/8_Supplement/1026.2.
  • Currie, J.C. et Annabi, B. (2006). Inhibition of HuR and MMP-9 expression in macrophage-differentiated HL-60 myeloid leukemia cells: A potential role for green tea catechins gallate against cancer-associated inflammation. Dans Proceedings of the 4th annual meeting of the Montreal Centre for Experimental Therapeutics in Cancer.
  • Wu, J.J., Garde, S., Dulude, H., Daigneault, L., Annabi, B., Béliveau, R., Rabbani, S.A. et Panchal, C. (2006). Inhibition of multiple signaling pathways by PCK3145 and its implication in the treatment of prostate cancer. Dans Proceedings of the 12th Prostate Cancer Foundation Retreat (Scottsdale, AZ, USA).
  • Duhamel, S., Meriane, M., Galipeau, J. et Annabi, B. (2006). La Sphingosine-1 phosphate, un facteur plaquettaire, induit le remodelage du cytosquelette d’actine et la migration des cellules souches mésenchymateuses. Dans 74e congrès de l’ACFAS (Montréal, QC, Canada).
  • McLaughlin, N., Annabi, B., Moumdjian, R., Bahary, J.P. et Béliveau, R. (2006). L’EGCg du thé vert potentialise la mort des cellules endothéliales cérébrales induite par l’irradiation [Résumé], Neurochirurgie, 52(5), 480. http://dx.doi.org/10.1016/S0028-3770(06)71281-4.
  • Currie, J.C. et Annabi, B. (2006). Un dérivé du thé vert, l’épigallocatechin-gallate EGCg, antagonise le potentiel invasif des cellules promyélocytaires transformées. Dans 74e congrès de l’ACFAS (Montréal, QC, Canada).
  • Belkaid, A., Currie, J.C., Desgagnés, J. et Annabi, B. (2006). Un nouveau rôle du transporteur microsomale de glucose-6-phosphate dans le caractère invasif des glioblastomes : effet anti-cancérigène de l’acide chlorogénique. Dans 74e congrès de l’ACFAS (Montréal, QC, Canada).
  • Annabi, B., Lamy, S., Garde, S., Wisniewski, J., Ruiz, M.T., Dulude, H., Daigneault, L., Panchal, C., Wu, J.J. et Béliveau, R. (2005). A prostate secretory protein 94 (PSP94)-derived synthetic peptide (PCK3145) antagonizes VEGF signalling in endothelial cells: Implication in tumor angiogenesis [Résumé], Cancer Research, 65(9, suppl.), 710, Abstract 3021. Récupéré de https://cancerres.aacrjournals.org/content/65/9_Supplement/710.3.
  • Annabi, B., Lee, Y.T., Baharay, J.P. et Béliveau, R. (2005). Actions synergiques de la radiothérapie et du thé vert : une nouvelle approche thérapeutique anticancéreuse. Dans Proceedings of the 1st International Conference on Pharmaceutical Drugs-Development, prescription and consumption: Interdisciplinary perspectives for a common future (Montreal, Canada).
  • Lejeune, L., François, M., Galipeau, J. et Annabi, B. (2005). Human marrow stromal cells and angiogenesis: A role for CD44? Dans Proceedings of the 3rd Annual meeting of the Montreal Centre for Experimental Therapeutics in Cancer (Montreal, QC, Canada).
  • Garde, S., Shukeir, N., Arakelian, A., Chen, G., Morin, C., Forté, A., Pelletier, I., Wisniewski, J., Ruiz, M., Panchal, C., Wu, J.J., Annabi, B., Béliveau, R. et Rabbani, S.A. (2005). Inhibition of angiogenesis and MMP-9 production by a synthetic peptide (PCK3145) in a syngeneic model of rat prostate cancer results in decreased tumor growth and skeletal metastasis in vitro and in vivo [Résumé], Cancer Research, 65(9, suppl.), 1373, Abstract 5835. Récupéré de https://cancerres.aacrjournals.org/content/65/9_Supplement/1373.2.
  • McLaughlin, N., Annabi, B., Bahary, J.P., Moumdjian, R. et Béliveau, R. (2005). Modulation de la radio-résistance des glioblastomes par les catéchines du thé vert [Résumé], Neurochirurgie, 51(5), 551. http://dx.doi.org/10.1016/S0028-3770(05)83610-0.
  • McLaughlin, N., Annabi, B., Bahary, J.P., Moumdjian, R. et Béliveau, R. (2005). Radioresistance of human glioblastomas: Modulation by green tea polyphenol (-) epigallocatechin-3-gallate [Résumé], The Canadian Journal of Neurological Sciences, 32(S1), S52. http://dx.doi.org/10.1017/S0317167100003310.
  • Perri, S.R., Annabi, B., Lejeune, L., François, M., Béliveau, R. et Galipeau, J. (2005). Soluble Human Plasminogen Kringle 5 Domain Acts as a 2-Pronged Anti-Cancer Agent Inhibiting Both Endothelial Cells and Tumor-Associated Macrophages [Résumé], Cancer Research, 65(9, suppl.), 708, Abstract 3013. Récupéré de https://cancerres.aacrjournals.org/content/65/9_Supplement/708.2.
  • McLaughlin, N., Annabi, B., Bahary, J.P., Moumdjian, R. et Béliveau, R. (2005). The green tea polyphenol (-) epigallocatechin-3-gallate inhibits the survivin-mediated radioresistant phenotype in glioblastomas. Dans Proceedings of the 3rd Annual meeting of the Montreal Centre for Experimental Therapeutics in Cancer (Montreal, QC, Canada).
  • Bouzeghrane, M., Annabi, B. et Béliveau, R. (2005). Therapeutic potential of the green tea catechin EGCg in targeting the infiltrating phenotype of brain tumors: Inhibition of RhoA/ROK-mediated CD44 cell surface shedding. Dans Proceedings of the 3rd Annual meeting of the Montreal Centre for Experimental Therapeutics in Cancer (Montreal, QC, Canada).
  • Bouzeghrane, M. et Annabi, B. (2005). Therapeutic potential of the green tea catechin EGCg in targeting the infiltrating phenotype of brain tumors: Inhibition of RhoA/ROK-mediated CD44 cell surface shedding. Dans Proceedings of the 1st International Conference on Pharmaceutical Drugs-Development, prescription and consumption: Interdisciplinary perspectives for a common future (Montreal, QC, Canada).
  • Bouzeghrane, M. et Annabi, B. (2005). Therapeutic potential of the green tea catechin EGCg in targeting the infiltrating phenotype of brain tumors: Inhibition of RhoA/ROK-mediated CD44 cell surface shedding. Dans Proceedings of the 1st Annual Meeting of the BioMed Research Center (Montreal, QC, Canada).
  • Annabi, B., Lee, Y.T., Bahary, J.P. et Béliveau, R. (2004). Actions synergiques de la radiothérapie et du thé vert : une nouvelle approche thérapeutique anticancéreuse. Dans 72e congrès de l’ACFAS (Montréal, QC, Canada).
  • Annabi, B., Thibeault, S. et Béliveau, R. (2004). Caveolar regulation of type I collagen-induced hyaluronic acid binding to U-87 glioma cells [Résumé], Cancer Research, 64(7, suppl.), 1162, Abstract 5035. Récupéré de https://cancerres.aacrjournals.org/content/64/7_Supplement/1162.1.
  • Perri, S.R., Nalbantoglu, J., Annabi, B., Koty, Z., Béliveau, R. et Galipeau, J. (2004). Gene-Modified Human Glioma Cells Producing Soluble Human Plasminogen Kringle 5 Peptide Suppress Brain Tumor Progression [Résumé], Molecular Therapy, 9(suppl. 1), S372. http://dx.doi.org/10.1016/j.ymthe.2004.06.915.
  • Thibeault, S., Annabi, B. et Béliveau, R. (2004). Mécanismes moléculaires régulant l’interaction des glioblastomes avec l’acide hyaluronique : rôle de MT1-MMP. Dans 72e congrès de l’ACFAS (Montréal, QC, Canada).
  • Rivard, M.E., Desrosiers, R.R., Annabi, B. et Béliveau, R. (2004). Régulation de certains ligands associés à LRP (récepteur associé des lipoprotéines de faible densité) durant la progression des tumeurs de Wilms. Dans 72e congrès de l’ACFAS (Montréal, QC, Canada).
  • Naud, E., Galipeau, J. et Annabi, B. (2004). Régulation paracrine et contribution des cellules souches mésenchymateuses à l’angiogénèse tumorale. Dans 72e congrès de l’ACFAS (Montréal, QC, Canada).
  • Pilorget, A., Annabi, B. et Béliveau, R. (2004). Un facteur plaquettaire, la sphingosine-1-phosphate, inhibe les propriétés angiogéniques des cellules endothéliales cérébrales. Dans 72e congrès de l’ACFAS (Montréal, QC, Canada).
  • Perri, S.R., Annabi, B., Béliveau, R. et Galipeau, J. (2003). Human plasminogen kringle 5 domain and potent endothelial cell-specific inhibitor for anti-angiogenic gene therapy of cancer [Résumé], Molecular Therapy, 7(5, suppl.), S127. http://dx.doi.org/10.1016/S1525-0016(16)40765-3.
  • Perri, S.R., Nalbantoglu, J., Annabi, B., Koty, Z., Béliveau, R. et Galipeau, J. (2003). Human Plasminogen Kringle 5 Domain, a Novel and Potent Endothelial Cell-Specific Inhibitor for Anti-Angiogenic Gene Therapy of Cancer. Dans Proceedings of the 10th Annual International Life Sciences Conference and Exhibition (BioNorth), (Ottawa, ON, Canada).
  • Pilorget, A., Annabi, B., Bousquet-Gagnon, N., Gingras, D. et Béliveau, R. (2002). Calmodulin inhibitors trigger the proteolytic processing of membrane type-1 matrix metalloproteinase, but not its shedding in glioblastoma cells. Dans Proceedings of the 2nd European Life Scientist Organization meeting (Nice, France), (p. 487).
  • Annabi, B., Lachambre, M.P., Pagé, M., Gingras, D. et Béliveau, R. (2002). Green tea polyphenol (-)-epigallocatechin-3-gallate antagonizes matrix metalloproteinases-mediated events in glioblastoma cells, Neuro-Oncology, 4, A5.
  • Annabi, B., Naud, E., Bousquet-Gagnon, N., Bernier, F., Galipeau, J. et Béliveau, R. (2002). Migration and capillary-like structure formation of mesenchymal stem cells (MSC): Are MSC involved in angiogenesis? Dans Proceedings of the 93rd American Association for Cancer Research, (vol. 43, p. 34).
  • Pilorget, A., Annabi, B., Bousquet-Gagnon, N., Gingras, D. et Béliveau, R. (2002). Modulation of the processing of MT1-MMP by calmodulin inhibitors in glioblastoma cells, Neuro-Oncology, 4, A39.
  • Al-Khaldi, A., Al-Sabti, H., Turcotte, S., Annabi, B., Béliveau, R., Galipeau, J. et Lachapelle, K. (2002). Role of hypoxia in mesenchymal stem cells related angiogenesis [Résumé], Journal of the American College of Surgeons, 195(3, suppl. 1), S20. http://dx.doi.org/10.1016/S1072-7515(02)01254-1.
  • Naud, E., Lee, Y.T., Annabi, B. et Béliveau, R. (2002). Régulation paracrine des propriétés angiogéniques des cellules souches mésenchymateuses. Dans 70e congrès de l’ACFAS.
  • Annabi, B., Lachambre, M.P., Gingras, D. et Béliveau, R. (2001). Multiple effects of EGCg on proMMP-2 secretion and activity in U-87 glioblastoma cells. Dans Proceedings of the 92nd American Association for Cancer Research, (vol. 42, p. 21).
  • Bousquet-Gagnon, N., Annabi, B., Gingras, D. et Béliveau, R. (2001). Rôle du domaine intracellulaire de la MT1-MMP (MMP-14) dans l'induction du caractère invasif des cellules COS-7. Dans 69e congrès de l’ACFAS.
  • Lachambre, M.P., Annabi, B., Pagé, M., Gingras, D. et Béliveau, R. (2000). L'activation de la proMMP-2 par la MT1-MMP est préférentiellement localisée dans les cavéoles de cellules tumorales. Dans 68e congrès de l’ACFAS.
  • Annabi, B., Lachambre, M.P., Pagé, M., Gingras, D. et Béliveau, R. (2000). MT1-MMP processing is preferentially localized within caveolae membrane. Dans Proceedings of the 91st American Association for Cancer Research, (vol. 41, p. 135).
  • Annabi, B., Lachambre, M.P., Gingras, D. et Béliveau, R. (2000). Mécanisme d'activation de la MMP-2 dans les cellules de glioblastomes humains : localisation cavéolaire et identification des domaines structuraux de la MT1-MMP, Médecine Sciences, 16(suppl. 2), 31.
  • Annabi, B., Lin, B., Hiraiwa, H., Pan, C.J. et Chou, J.Y. (1998). Cloning and expression of cDNAs encoding candidate murine and rat glycogen storage disease type 1b proteins, American Journal of Human Genetics, 63(suppl. 4), A262.
  • Pan, C.J., Annabi, B. et Chou, J.Y. (1998). Transmembrane topology of glucose-6-phosphatase, The FASEB Journal, 12(suppl. 8), A1447.
  • Annabi, B. et Van de Werve, G. (1997). The transit of glucose into liver microsomes is not required for functional glucose-6-phosphatase, The FASEB Journal, 11(3), 1742.
  • Annabi, B. et Van de Werve, G. (1997). Triamcinolone increases glucose-6-phosphatase without affecting glucose transport into liver microsomes, Archives of Physiology and Biochemistry, 105, B2.
  • Annabi, B., Van de Werve, G. et Rider, M.H. (1996). Inactivation of rat liver microsomal glucose 6-phosphatase by dicyclohexylcarbodiimide and evidence for the role of carboxyl groups in catalysis, The FASEB Journal, 10(3), 4485.
  • Annabi, B., St-Denis, J.F., Khoury, H. et Van de Werve, G. (1995). Histone II-A stimulates glucose-6-phosphatase and reveals mannose-6-phosphatase activities without permeabilization of liver microsomes. Dans XIIIe Atelier Annuel du Groupe de Recherche en Transport Membranaire. Montréal, Canada.
  • Berteloot, A., St-Denis, J.F., Vidal, H., Annabi, B., Romanelli, A., Larue, M.J., Tchu, S. et Van de Werve, G. (1995). Rapid Kinetic studies of the glucose-6-phosphatase system. Dans XIIIe Atelier Annuel du Groupe de Recherche en Transport Membranaire. Montréal, Canada.
  • Annabi, B., St-Denis, J.F. et Van de Werve, G. (1994). Orthovanadate inhibits both the phosphohydrolase activity of a 64 kDa glucose-6-phosphatase and the efflux of glucose from rat liver microsomes, Canadian Journal of Physiology and Pharmacology, 72(suppl. 3), 19.
  • St-Denis, J.F., Vidal, H., Berteloot, A., Annabi, B. et Van de Werve, G. (1993). Characterization of glucose transport in rat liver microsomes, Diabetes, 42(suppl. 1), 125A.
  • Annabi, B. et Van de Werve, G. (1993). Partial purification of a stable form of liver microsomal glucose-6-phosphatase, Diabetes, 42(suppl. 1), 125A.
  • Annabi, B. et Van de Werve, G. (1993). Purification partielle et caractérisation d'une forme stable de la glucose-6-phosphatase hépatique de rat. Dans XIIe Congrès de l'Association des Étudiant(e)s aux Grades Supérieurs de la Faculté de Médecine de l'Université de Montréal. Montréal, Canada.
  • Annabi, B., Massillon, D., Lavoie, L. et Van de Werve, G. (1992). Défauts du métabolisme du glycogène hépatique étude étiologique chez le rat Zucker génétiquement (fa/fa) obèse, Médecine Sciences, suppl. 2, 13.
  • Annabi, B. et Van de Werve, G. (1992). Purification partielle et caractérisation de la glucose 6-phosphatase hépatique. Dans Résumés du Congrès Annuel de l'Association du Diabète du Québec. Montréal, Canada.